Inference After Selecting Plausibly Valid Instruments with Application
  to Mendelian Randomization by Bi, Nan et al.
Inference After Selecting Plausibly Valid Instruments
with Application to Mendelian Randomization
Nan Bi1, Hyunseung Kang2, and Jonathan Taylor1
1Department of Statistics, Stanford University
2Department of Statistics, University of Wisconsin-Madison
Abstract
Mendelian randomization (MR) is a popular method in genetic epidemiology to estimate the effect
of an exposure on an outcome by using genetic instruments. These instruments are often selected from a
combination of prior knowledge from genome wide association studies (GWAS) and data-driven instru-
ment selection procedures or tests. Unfortunately, when testing for the exposure effect, the instrument
selection process done a priori is not accounted for. This paper studies and highlights the bias resulting
from not accounting for the instrument selection process by focusing on a recent data-driven instrument
selection procedure, sisVIVE, as an example. We introduce a conditional inference approach that con-
ditions on the instrument selection done a priori and leverage recent advances in selective inference to
derive conditional null distributions of popular test statistics for the exposure effect in MR. The null
distributions can be characterized with individual-level or summary-level data in MR. We show that our
conditional confidence intervals derived from conditional null distributions attain the desired nominal
level while typical confidence intervals computed in MR do not. We conclude by reanalyzing the effect
of BMI on diastolic blood pressure using summary-level data from the UKBiobank that accounts for
instrument selection.
Keywords: Anderson-Rubin test, selective inference, sisVIVE, summary data, two-stage least squares
1 Introduction
1.1 Motivation: Mendelian Randomization and Selecting Instruments
Mendelian randomization (MR) (Davey Smith and Ebrahim, 2003, 2004; Burgess and Thompson, 2015)
has become a popular tool to estimate the effect of an exposure or a treatment on an outcome. In a
nutshell, MR utilizes instrumental variables (IV), a popular method in causal inference, epidemiology, and
economics (Angrist and Krueger, 2001; Herna´n and Robins, 2006; Baiocchi et al., 2014) and large genome
wide association studies (GWAS) to find genetic variants, typically single nucleotide polymorphisms (SNPs)
and called genetic instruments, that satisfy the three core assumptions:
(A1) the instruments are associated with the treatment
(A2) the instruments have no direct effect on the outcome conditional on the treatment value
(A3) the instruments are unconfounded;
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See Section 2.2 for formal mathematical definitions in our model. If the magnitude of the association in (A1)
is large, instruments are said to be strong and if the magnitude is small, instruments are said to be weak. If
instruments satisfy (A2) and (A3), they are referred to as valid instruments (Murray, 2006).
A standard MR analysis starts by selecting SNPs/instruments that satisfy the three assumptions, espe-
cially the first two assumptions (A1) and (A2); (A3) is generally assumed to hold in MR studies (Burgess
and Thompson, 2015). Selecting instruments that satisfy (A1) is typically based on prior GWAS that show
strong links between the SNPs and the exposure of interest. Selecting instruments that satisfy (A2) requires
SNPs to only affect the outcome via the exposure; SNPs must not have pleiotropic effects or affect other
variables which affect the outcome (Solovieff et al., 2013). Unfortunately, finding non-pleiotropic instru-
ments is a challenge in MR, especially if the biomarker and/or the outcome are complex traits (Little and
Khoury, 2003; Thomas and Conti, 2004; Brennan, 2004; Lawlor et al., 2008), and many MR investigators
use a combination of subject-matter expertise, prior GWAS, and ad-hoc association tests, to assess (A2).
More recently, data-driven methods have been proposed to select instruments that plausibly satisfy (A2)
under the assumption of a linear MR model (Andrews, 1999; Kang et al., 2016; Windmeijer et al., 2016; Guo
et al., 2016); see Section 2.2 for details. Once instruments are selected to plausibly satisfy (A1) to (A3),
the effect of the exposure on the outcome is estimated and tested. The two most common inferential goals
are (i) testing the null hypothesis of no effect H0 : β
∗ = 0 where β∗ is the parameter for the effect of the
exposure on the outcome and (ii) constructing a 95% confidence interval of β∗.
As a concrete example of a standard MR analysis, Vimaleswaran et al. (2013) studied the causal effect of
obesity, as measured by the body mass index (BMI), on serum vitamin D levels. To satisfy (A1), the authors
selected 12 SNPs strongly associated to BMI based on prior GWAS by Loos et al. (2008), Thorleifsson et al.
(2008), Li et al. (2009), and Speliotes et al. (2010). They also tested the 12 SNPs for violations of (A2)
by conducting an association test between each SNP and the outcome; see Table S6 of Vimaleswaran et al.
(2013). After these checks, the 12 SNPs were then used to infer BMI’s effect on vitamin D by using a variant
of two-stage least squares (TSLS), a popular method in IV; see Lawlor et al. (2008) and Section 2.3 for
details on TSLS in MR settings. They reported a p-value of 0.005 for the null hypothesis of no effect of
BMI on serum vitamin D levels with a 95% confidence interval of (−0.71,−0.13) and concluded that BMI is
negatively associated with serum vitamin D levels.
1.2 Inferring Treatment Effects After Selection
Unfortunately, the standard approach of inferring treatment effects and deriving p-values for the null of no
treatment effect neglect the instrument selection process done a priori. In MR, the SNPs/instruments were
selected (or discarded) from a large pool of potential SNPs from GWAS whereby the “best” instruments were
selected and the “worst” instruments were discarded based on a combination of subjective-matter expertise
and quantitative analysis. Also, in many MR studies, including Vimaleswaran et al. (2013), the same data
is used to select the instruments as well as to test the exposure effect. Yet, when testing this effect by
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computing the p-value or the confidence interval, the statistical analysis simply assumes that the selected
instruments are given “as is” and the prior selection process is neglected. Formally speaking, the p-value or
the confidence interval for the exposure effect is not conditional on the event that the “best” instruments
were selected into the analysis.
For example, going back to Vimaleswaran et al. (2013), the final p-value 0.005 of the exposure effect and
the 95% confidence interval were computed under the assumption that the 12 selected SNPs were drawn
from a population of exactly 12 instruments. In reality, the 12 SNPs are the “best” SNPs from a larger pool
of SNPs from GWAS and they were carefully selected for IV strength and validity, all in order to obtain the
“best” exposure effect. Consequently, when conditioning on the selection process, the authors’ significant
p-value may over-represent the true statistical significance of the treatment effect when none actually exist
and increase Type I error. Similarly, the confidence intervals may be optimistically too short.
1.3 Prior Work
Informally, the problem above goes by many names such as the “file drawer effect” (Fithian et al., 2014; Taylor
and Tibshirani, 2015) or “p-hacking” (Simmons et al., 2011; Gelman and Loken, 2013), where researchers
only report the final statistical analysis and ignore prior analysis, such as variable selection, that led up to
the final analysis. Some recent work have framed the problem as selective inference and showed that ignoring
variable selection when testing a hypothesis can lead to inflated Type I errors and biased confidence intervals
(Fithian et al., 2014; Lee and Taylor, 2014; Taylor et al., 2014; Tian et al., 2016; Bi et al., 2017). In Section
4, we also show that this phenomena holds in MR, where the typical confidence interval from MR ignoring
instrument selection can have coverage much lower than the nominal level in many cases.
To the best of our knowledge, none of the work in MR considered testing the treatment effect that takes
into account instrument selection. Much of the recent work in MR has focused on estimation when some
instruments may violate the IV assumptions (Bowden et al., 2015; Kang et al., 2015; Bowden et al., 2016;
Burgess et al., 2016; Windmeijer et al., 2016; Kang et al., 2016; Guo et al., 2016; Hartwig et al., 2017).
Works by Small (2007) and Conley et al. (2012) discuss sensitivity analysis as a way to conduct inference
when the selected instruments are invalid. However, none of these work addressed the issue of calibrating
inference of the exposure effect after instrument selection has taken place.
1.4 Our Contribution
In this paper, we propose a method to generate honest p-values and confidence intervals for the treatment
effect. Our method is honest in that it accounts for the instrument selection process when computing
statistical significance of the exposure effect. We focus on an instrument selection procedure by Kang et al.
(2016) called sisVIVE, which operationalized the MR investigator’s instrument selection process by choosing
s instruments from a pool of L candidate instruments based on a procedure similar to the Lasso (Tibshirani,
1996); sisVIVE was further analyzed by Windmeijer et al. (2016) for its selection properties. We propose
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a flexible and general sampling method to generate the conditional null distribution (i.e. conditional on
selecting the instrument(s)) of pre-existing test statistics T for the exposure effect β∗. We provide two
examples of our sampling method by deriving the conditional distribution of two popular test statistics,
the aforementioned TSLS, which is the most popular test statistic in MR, and the Anderson-Rubin test
statistic (Anderson and Rubin, 1949), which is fully robust against weak instruments (Staiger and Stock,
1997). We show that our method controls the conditional Type I error of a test T accounting for selection
and provides conditional confidence intervals for the treatment effect that takes into account instrument
selection; the conditional Type I error is also referred to as selective Type I error (Fithian et al., 2014).
Also, as long as sisVIVE selects instruments which contain all invalid instruments with high probability, our
conditional method also controls the usual marginal Type I error and the conditional confidence interval has
the usual marginal coverage; here, marginal Type I error and marginal coverage refers to the usual inferential
properties that do not condition on a set of instruments. We also extend our sampling approach to work with
summary-level data, a popular data format in MR where only summary statistics from GWAS are available
to study the exposure effect (Burgess et al., 2013; Pierce and Burgess, 2013).
We recognize that in practice, MR investigator may use a combination of data-driven selection algorithms
(Andrews, 1999; Andrews and Lu, 2001; Windmeijer et al., 2016; Guo et al., 2016) including sisVIVE and/or
subjective knowledge to select the final s instruments that are plausibly valid. We focus on sisVIVE because
unlike subjective selection of instruments, sisVIVE formalizes the instrument selection process and as such,
is tractable to quantitatively characterize the selection effects on inference; in contrast, the effect of selection
based on subject-matter knowledge is difficult to formalize since it is investigator-dependent and different
investigators may use a wide variety of methods for instruments selection. Also, some instrument selection
methods are computationally expensive (Andrews, 1999; Andrews and Lu, 2001). Bi et al. (2017) describes
a general interactive data analysis framework that might encompass these possibilities.
Despite the caveats, we believe our method is a more honest alternative than the traditional practice of
simply ignoring how instrument selection occurred. By studying a particular example of instrument selection,
we hope to bring attention to this problem to the MR community. We also point out ways to extend our
framework beyond sisVIVE. In particular, our framework is applicable as long as the instrument selection
process is expressed in terms of a convex program, and the test statistic for the exposure is asymptotically
Normal.
2 Instrumental Variables Model
2.1 Notation
For each individual i = 1, . . . , n, let Yi ∈ R be the outcome, Di ∈ R be the treatment/endogenous variable,
and Zi ∈ RL be the L candidate instruments. Let Y = (Y1, . . . , Yn), D = (D1, . . . , Dn), and Z ∈ Rn×L of
instruments. For any full rank matrix Z ∈ Rn×L, let PZ = Z(ZᵀZ)−1Zᵀ be the orthogonal projection matrix
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onto the columns of Z and PZ⊥ = I − PZ be the residual orthogonal projection matrix. For any real vector
v, let sign(v) denote the vector of the signs of v. For any set E ⊆ {1, . . . , L}, let |E| be the cardinality of the
set E and EC be the complement. Let ZE and Z−E be the n by |E| and n by L−|E| matrices, respectively,
where the columns consist of the elements in the sets E and {1, . . . , L} \ E, respectively. Let det(·) denote
the determinant of a matrix. Let I(·) be the indicator function. Let 1 denote an all-one vector of dimension
implied from context. We adopt the usual big-O and small-O notations, O(·) and o(·), to denote the order
of a function.
2.2 Review: Model and Definition of IV
We follow the MR literature, specifically Burgess et al. (2016) and Bowden et al. (2017a), and consider an
additive, linear, constant effects structural model that governs the distribution of the observed outcome,
exposure, and instruments (Yi, Di, Zi):
Yi = Z
ᵀ
i α
∗ +Diβ∗ + δi
Di = Z
ᵀ
i γ
∗ + ξi2
(δi, ξi2 | Zi) i.i.d.∼ H(0,Σ∗), Zi i.i.d.∼ F
(1)
The unknown finite-dimensional parameters in the model are α∗, β∗, γ∗, and Σ∗. The instruments Zi. for
individual i is generated from a distribution F where E(Zi) and E(ZiZ
ᵀ
i ) exist and E(ZiZ
ᵀ
i ) is positive
definite. The distribution of the errors H is any bivariate distribution with mean zero and covariance Σ∗
that does not depend on Zi; typically, H is assumed to be bivariate Normal. Also, without loss of generality,
we assume that Y , D, and Z have been centered to mean zero, which allows us to remove the intercept
terms in equation (1). We can also incorporate exogenous covariates X as a linear additive term to model
(1) and project X out to arrive back at the structural model in (1); see chapters 2.4 and 2.5 of Davidson
and MacKinnon (1993) or equation 2.3 of Andrews et al. (2006) for examples.
The target parameter for inference is β∗, which represents the effect of the exposure on the outcome.
Parameter α∗ in model (1) represents a combination of the instruments’ direct effect on the outcome as well
as the confounding effect due to unmeasured confounders of the exposure-outcome relationship; see Section
2 of Bowden et al. (2017a) for detailed interpretations of these parameters. If all instruments are valid and
therefore satisfy (A2) and (A3), we have α∗ = 0 and equation (1) would reduce to the usual instrumental
variables model. If some instruments are invalid, α∗ 6= 0 and (A2) or (A3) would be violated. In short, the
parameter α∗ can be used to define assumptions (A2) and (A3), which we state below.
Definition 1. Suppose we have L candidate instruments along with model (1). We say that instrument
j = 1, . . . , L satisfies both (A2) and (A3), or is valid, if α∗j = 0 and is invalid if α
∗
j 6= 0.
Definition 1 is identical to MR’s definition of invalid and valid instruments (Bowden et al., 2016; Burgess
et al., 2016). Definition 1 also matches the definition of a valid instrument in Holland (1988) and Angrist
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et al. (1996) if there is a single instrument (i.e L = 1). When there are several instruments (i.e. L > 1),
Definition 1 can be viewed as a generalization of the definitions in Holland (1988) and Angrist et al. (1996).
Parameter γ∗ in model (1) represents the instruments’ associations to the exposure and we can use its
support to formalize (A1) as follows.
Definition 2. Suppose we have L candidate instruments along with model (1). We say that instrument
j = 1, . . . , L satisfies (A1), or is a non-redundant IV, if γ∗j 6= 0.
In MR, all instruments are generally assumed to be marginally associated with the treatment, i.e. γ∗j 6= 0
for all j. Also, when there is only one candidate instrument (i.e. L = 1), Definition 2 of (A1) is a special
case of the more general definition of (A1) in Angrist et al. (1996).
2.3 Review: Point Estimators and Test Statistics
We review point estimators of the model parameters and test statistics for β∗. Additional details can be
found in the supplementary materials where we enumerate the exact technical conditions and derive their
statistical properties.
Consider any set E ⊆ {1, . . . , L} of the plausibly invalid instruments where E∗ ⊆ E and γ∗EC 6= 0. The
most popular and consistent estimator for β∗ is the two stage least squares (TSLS) estimator
β̂TSLS =
Dᵀ(PZ − PZE )Y
Dᵀ(PZ − PZE )D
(2)
For inference of β∗, we need a consistent estimator of the covariance Σ∗ in model (1). One such estimator
is by plugging in the estimator β̂TSLS into model (1) and residualizing
Σ̂(β̂TSLS) =
1
n
(
Y −Dβ̂TSLS D
)ᵀ
PZ⊥
(
Y −Dβ̂TSLS D
)
,
(
Y −Dβ̂TSLS D
)
∈ Rn×2
Alternatively, we can construct a consistent estimator of Σ∗ under the null hypothesis H0 : β∗ = β0 by
replacing β̂TSLS with the null value β0:
Σ̂(β0) =
1
n
(
Y −Dβ0 D
)ᵀ
PZ⊥
(
Y −Dβ0 D
)
(3)
For testing the null hypothesis H0 : β
∗ = β0, we review two popular tests. The first is based on the
two-stage least squares (TSLS) and is defined as
TTSLS =
Dᵀ(PZ − PZE )(Y −Dβ0)√
Σ̂11
√
Dᵀ(PZ − PZE )D
(4)
where Σ̂11 is a consistent estimator of Σ
∗
11, a component of Σ
∗. Under standard asymptotic arguments (c.f.
Section 5.2.2 of Wooldridge (2010)), TTSLS converges to a standard Normal under H0. The second test
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statistic is the Anderson-Rubin (AR) test (Anderson and Rubin, 1949) and is defined as
TAR =
(Y −Dβ0)ᵀ(PZ − PZE )(Y −Dβ0)/(L− |E|)
(Y −Dβ0)ᵀPZ⊥(Y −Dβ0)/(n− L)
(5)
Under H0 and if the errors in model (1) are a bivariate Normal, TAR follows an F distribution with degrees
of freedom L−|E| and n−L. A unique feature about the Anderson-Rubin test is that if the instruments are
weak, it still provides valid Type I error control whereas the TSLS test does not (Staiger and Stock, 1997).
2.4 Review: Instrument Selection with sisVIVE
Kang et al. (2016) proposed a data-driven method to select valid instruments from a candidate set of L
instruments under model (1). The algorithm, called sisVIVE, is a modification of the Lasso where we take
model (1) and penalize the parameter α, whose support defines valid and invalid instruments in Definition
1.
α̂, β̂ ∈ argmin
α,β
1
2
||PZ(Y − Zα−Dβ)||22 + λ||α||1, 0 < λ (6)
Under some conditions, Kang et al. (2016) showed that the estimate β̂ is consistent for β∗. Windmeijer et al.
(2016) studied the instrument selection property by analyzing the support of αˆ and provided conditions
where sisVIVE consistently selects valid instruments. sisVIVE has been used by MR investigators, such as
Allard et al. (2015) and Bao et al. (2019), who selected instruments based on sisVIVE and conducted further
analysis of β∗ with the selected instruments. Unfortunately, both papers did not adjust their test of β∗ to
account for instrument selection from sisVIVE. Our goal is to address the inferential issues after instrument
selection as formalized in the next section.
2.5 Statistical Goal: Pivotal Conditional Inference
Let E = supp(α̂) be the set of selected invalid instruments from sisVIVE. In MR, the traditional inferential
goals are to test the null hypothesis of the exposure effect H0 : β
∗ = β0 for some β0 where the Type I error
is under a pre-specified pi, 0 < pi < 1, and to construct a corresponding 1 − pi confidence interval for β∗.
Typically, this is done by using a test statistic T and deriving a pivotal null distribution of T that does not
depend on unknown parameters.
PH0:β∗=β0(T ≥ t), t ∈ R (7)
However, as mentioned in Section 1.2, the null distribution in equation (7) fails to recognize two things.
First, the selected set of invalid instruments E is random because it is a function of the data Y , D, and Z,
which in turn was randomly sampled. But, the traditional derivation of the null distribution assumes E to
be pre-specified and fixed. Second, the null distribution does not reflect that instrument selection has taken
place. In fact, a statistical quantity that addresses these two concerns and consequently, is a better reflection
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of a typical MR analysis would be a conditional null
PH0:β∗=β0(T ≥ t | E was selected)
For sisVIVE, a variant of the above is a finer conditioning event
PH0:β∗=β0(T ≥ t | supp(α) = E, sign(αE) = ŝE), t ∈ R (8)
Here, α is the optimization variable in (6), E is the observed selected set of invalid instruments and ŝE is
the observed sign of α̂E , the latter two from sisVIVE (6). The condition supp(α) = E represents selecting
E instruments from sisVIVE and consequently, restricting the support of α in the model. The condition
sign(αE) = ŝE represents observing the estimated signs of the direct effects from selected instruments. For
example, among a pool of L = 100 instruments, if the first ten were selected from sisVIVE, E = {1, . . . , 10}
and sign(αE) would be set to the signs of the first 10 instruments estimated from sisVIVE. Unlike the
marginal null in equation (7), the conditional null in equation (8) acknowledges that the invalid instruments
E were selected from a pool of L instruments, in this case with sisVIVE, and we observed which direction
the invalid instruments affected the outcome before testing the exposure effect β∗. Practically speaking,
equation (8) resembles the MR analysis in Allard et al. (2015) where the authors tested H0 after selecting
instruments using sisVIVE. and is a more true-to-life representation of an MR analysis for the exposure effect
than the traditional null distribution (7) that ignores instrument selection. Also, while we do not explore
it in this paper, one can also study a modified version of (8) without conditioning on the signs by taking
unions of different sign patterns and integrating it out from (8); see Lee et al. (2016) for details.
If the conditional distribution in equation (8) is pivotal, it allows us to construct tests and confidence
intervals that control the conditional Type I error at level pi
PH0:β∗=β0(reject H0 | supp(α) = E, sign(αE) = ŝE) ≤ pi
and conditional coverage of β∗ at 1− pi (Fithian et al., 2014; Bi et al., 2017). The conditional Type I error,
unlike the traditional Type I error, i.e. PH0:β∗=β0(reject H0), takes into account instrument selection that
was done a priori. Also, as long as EC only contains valid instruments, any test that controls the conditional
type I error at level pi and achieves nominal conditional coverage will control the usual Type I error at level
pi and achieve the usual 1− pi coverage.
Since the conditional null distribution plays a key role in achieving our inferential goals, the rest of the
paper is devoted to charactering it.
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2.6 Why Not Sample Splitting?
One solution to deriving the conditional distribution in equation (8) is sample splitting, where a subset of
the sample is used to select the instruments and the rest of the unused samples is used to compute the
test statistic; this is also the approach taken by Burgess et al. (2011); Zhao et al. (2018a). Under this
sampling scheme, the conditional null simply becomes the marginal null and the traditional inference will
be honest. However, a major shortcoming with data splitting is that there is a loss in sample size in both
testing and selecting instruments; we are using fewer samples to select good instruments and to test for
exposure effect. Indeed, if the effect size is small, the loss of power from sample splitting would make it
difficult to discover such effects. Fithian et al. (2014) also proved under general conditions that sample
splitting is inadmissible to another procedure called data carving , which uses entire dataset for inference
after conditioning on the selection result. They also showed that data carving with holdout significantly
boosts power of a test compared to no holdout. Our method described in Section 3 also uses a type of data
carving with holdout where we randomize the instrument selection algorithm.
Also, in practice, MR investigators use the same sample to assess the validity of their selected instru-
ments; see Voight et al. (2012) and Allard et al. (2015) for examples. This is partly because to achieve full
independence between the selection event and the computation of the test statistic, MR investigators have
to find three independent GWAS that measured the exposure and the outcome, which may be difficult for
non-common exposures or outcomes.
3 Sampling Method for the Pivotal Conditional Null Distribution
We characterize the conditional null distribution in equation (8) using a hit-and-run sampling procedure.
The sampling procedure is roughly divided into three parts: the randomized selection algorithm, the
reparametrization of (8) to simplify the conditioning event E, and a standard hit-and-run or MCMC sam-
pling algorithm. To simplify discussion, we begin by initially assuming (i) Z is fixed and (ii) the nuisance
parameters α∗, γ∗, and Σ∗ are known. Section 10.2 removes the two restrictions by deriving an asymptotic
version of the conditional null distribution.
3.1 Randomized Instrument Selection
The first step in our method is to recast sisVIVE (6) as a randomized instrument selection algorithm
(α̂, β̂) = argmin
α,β
1
2
‖PZ(Y − Zα−Dβ)‖22 + λ||α||1 − ωᵀ ·
 β
α
+ 
2
∥∥∥∥∥∥
 β
α
∥∥∥∥∥∥
2
2
(9)
The randomization term ω comes from a density g(ω) that is specified by the investigator and is independent
of Y and D, typically Gaussian, Laplacian or other heavy tailed distributions with variance on the order of
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O(n). The quadratic term ensures strong convexity and existence of a solution. The penalty term λ and 
are chosen so that its order is O(n
1
2 ) and o(1), respectively; see Section 4 for examples of these values.
The idea of randomizing the original selection algorithm to derive conditional nulls was proposed by Tian
and Taylor (2016). The authors showed that a randomized algorithm is mathematically equivalent to data
carving with holdout. More generally, randomized selection algorithms belong to a family of resampling
algorithms, such as sample splitting and cross validation. However, the randomized selection algorithm in
(9) has some advantages, especially compared to sample splitting. First, as mentioned in Section 2.6, using
(9) increases the power to test the exposure effect. Second, the randomized algorithm allows any pre-existing
test statistics for the exposure effect to be used for downstream analysis; we do not have to create a new
test statistic so that the conditional Type I error is controlled. Finally, as we’ll see below, the conditional
density under (9) becomes tractable for off-the-shelf hit-and-run and MCMC algorithms.
3.2 Exact Conditional Density
Under a fixed Z, let `(Y,D, ω | supp(α) = E, sign(αE) = ŝE) denote the density of the data Y,D and the
known independent randomization term ω conditional on the same selection events. Let `(Y,D | supp(α) =
E, sign(αE) = ŝE) denote the density of the data (Y,D) that marginalized out ω from the first density.
Given samples of Y and D from the conditional density, the conditional density of the test statistic T (Y,D)
is simply a plug-in of Y and D into T (Y,D). In short, to obtain a conditional distribution of T (Y,D), we
need to characterize `(Y,D, ω | supp(α) = E, sign(αE) = ŝE).
Directly sampling the conditional density of (Y,D, ω) requires solving sisVIVE until the conditioning
events {supp(α) = E, sign(αE) = ŝE} are met, which can be a computationally expensive task. Importantly,
the restrictions that the conditioning events impose on the data Y and D are non-trivial, making it difficult
to analytically marginalize out ω. But, by reparametrizing `(Y,D, ω | supp(α) = E, sign(αE) = ŝE) with a
familiar change-of-variables formula, we can alleviate these two concerns. Specifically, the reparametrization
is based on the convexity in equation (9), which implies that the solutions α, β to the optimization must
satisfy the Karush-Kuhn-Tucker (KKT) condition (Boyd and Vandenberghe, 2004)
−
 Dᵀ
Zᵀ
PZ(Y −Zα−Dβ) +λ
 u
0
−ω+ 
 α
β
 = 0, sign(αE) = uE = ŝE, α−E = 0, ‖u−E‖∞ ≤ 1
where ŝE is the observed signs for the set E, α, β are the optimization variables and u is the subgradient. We
remind readers that we use α, β, u to denote the optimization variables of (9) and α̂, β̂, û to denote a specific
solution of the optimization in (9) from the dataset. Importantly, the KKT condition provides a mapping
between the density of (Y,D, ω) and the density based on the optimization variables (Y,D, β, αE , u−E) by
using a change-of-variable formula.
Theorem 1 (Exact conditional density via reparametrization). The conditional density of Y,D, ω can be
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expressed (up to a proportionality constant) with respect to the variables Y,D, β, α, u, i.e.
`(Y,D, ω | supp(α) = E, sign(αE) = ŝE)
∝f(Y,D) · g
−
 Dᵀ
Zᵀ
PZ(Y − Zα−Dβ) + λ
 u
0
+ 
 α
β
 · |J | · I(B) (10)
where B = {sign(αE) = ŝE , α−E = 0, uE = ŝE , ‖u−E‖∞ ≤ 1} and
|J | = det
DᵀPZD DᵀZE
ZᵀED Z
ᵀ
EZE
+ I
 · λ|−E|
In addition to the reparametrization, Theorem 3 shows the effect that conditioning on instrument selection
has on the original data density Y,D, represented by f(Y,D) in (18). The terms on the right hand side of
f(Y,D) essentially reweigh and constrain the distribution of Y and D to reflect that selecting the instruments
from (9) changed the original data density. The constraints on Y and D are expressed by optimization
variables where the original conditioning event, {supp(α) = E, sign(αE) = ŝE}, is re-expressed as the event
B. B is special in that it is a set of simple quadrant and box constraints on said optimization variables
compared to the original conditioning event. Now, if the original data density f(Y,D) is known, i.e. if we
know the model parameters α∗, γ∗,Σ∗, the density is pivotal with respect to these parameters and one can
directly use (18) in an MCMC sampler to generate samples of Y and D, which can then be used to compute
the conditional null distribution of any test statistic for the exposure effect. However, in practice, these
model parameters, i.e. f(Y,D), are unknown and act as nuisance parameters. The next section remedies
this issue by conditioning on an asymptotic sufficient statistics of the nuisance parameters in f(Y,D) and
deriving an asymptotic conditional density of the test statistic T .
3.3 Asymptotic pivotal conditional densities of TSLS and AR test statistics
In this section, we present the conditional density of the TSLS and the AR test statistics in Section 2.3.
The key technical step is to apply the selective central limit theorem (CLT) which was proposed in Markovic
and Taylor (2017). We state the results of applying the theorem in the main paper and the supplement
contains additional details. Throughout this section, Y,D,Z and functions thereof, such as T̂ , β̂, α̂, and
û are observed values (i.e. fixed) and the sampling variables (i.e. those used in the sampling procedure to
generate conditional null distributions) are T , β, α, and u.
For the TSLS test statistic TTSLS in equation (4), Section 2.3 showed that it asymptotically follows a
standard Normal with mean µT = 0 and variance ΣT = 1, which we denote as φ(0,ΣT )(TTSLS). By utilizing
the selective CLT, the asymptotic conditional density of TTSLS under the null hypothesis H0 : β
∗ = β0 is the
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reweighing of the usual density of φ(0,ΣT )(TTSLS):
`β0(TTSLS, ω | supp(α) = E, sign(αE) = ŝE , F )
∝ φ(0,ΣT )(TTSLS) · g
−ΣS,TΣ−1T · TTSLS +
ZᵀZ ZᵀD
DᵀZ DᵀPZD
+ I
 ·
α
β
+ λu− F
 · |J | · I(B) (11)
where
ΣT = 1, ΣS,T =
√
Σ̂11
Dᵀ(PZ − PZE )D
Zᵀ(PZ − PZE )D
Dᵀ(PZ − PZE )D

F =
 ZTY
DTPZY
− ΣS,TΣ−1T · T
and T is the test statistic. The term F is, in the asymptotic sense, a sufficient statistic for the unknown
parameters of the data distribution Y,D and conditioning on it frees us from these nuisance parameters,
akin to conditioning on sufficient statistics in a parametric bootstrap for linear regression; see Markovic and
Taylor (2017) and the supplementary materials for a detailed explanation.
Similarly, let φ(β0,ΣT )(βTSLS) denote the density of the TSLS estimator βTSLS in equation (15). We can
also derive the conditional distribution of the TSLS estimator as a direct application of the selective CLT.
`β0(βTSLS, ω | supp(α) = E, sign(αE) = ŝE , F )
∝ φ(β0,ΣT )(βTSLS) · g
−ΣS,TΣ−1T · βTSLS +
ZᵀZ ZᵀD
DᵀZ DᵀPZD
+ I
α
β
+ λu− F
 · |J | · I(B)
(12)
where F is identical as before except for the test statistic and the variances and
ΣT =
Σ̂11
Dᵀ(PZ − PZE )D
, ΣS,T =
Σ̂11
Dᵀ(PZ − PZE )D
Zᵀ(PZ − PZE )D
Dᵀ(PZ − PZE )D

For the Anderson-Rubin test statistic TAR, let T˜ ∈ RL be an intermediary sampling target
T˜ = Zᵀ(I − PZE )(Y −Dβ0)
and φ[0,ΣT ](T˜ ) be the unconditional density of T˜ . Then, the conditional sampling density of T˜ under the
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null H0 : β
∗ = β0 is given by:
`β0(T˜ , ω | supp(α) = E, sign(αE) = ŝE , F )
∝ φ[0,ΣT ](T˜ ) · g
−ΣS,TΣ−1T T˜ +
ZᵀZ ZᵀD
DᵀZ DᵀPZD
+  · I
α
β
+ λu− F
 · |J | · I(B) (13)
where F is identical as before except for the test statistic and the variances and
ΣT = Σ̂11 · Zᵀ(I − PZE )Z, ΣS,T = Σ̂11 ·
Zᵀ(I − PZE )Z
Dᵀ(I − PZE )Z

We can then generate samples of the Anderson-Rubin test TAR by sampling T˜ from (25) and plugging into
TAR =
T˜ ᵀ · (ZᵀZ)−1 · T˜ /(L− |E|)
(Y −Dβ0)ᵀPZ⊥(Y −Dβ0)/(n− L)
(14)
to generate conditional null distributions of TAR under instrument selection.
3.4 Sampling Algorithm
Given the conditional density of a test statistic, we can use any off-the-shelf MCMC sampling method to
sample values of the test statistic. We detail one Gibbs sampling algorithm and characterize the conditional
density of the TSLS test statistic in (22).
Let K1,K2, and K3 be the following quantities.
K1 = −ΣS,T , K2 =
ZᵀZ ZᵀD
DᵀZ DᵀPZD
+  · I
 , K3 =
 ZᵀY
DᵀPZY
− ΣS,T · T̂TSLS

These variables are observed values from the data and hence fixed constants in the sampler. Then, the
conditional null density in (22) is proportional to
`β0(t, ω | supp(α) = E, sign(αE) = ŝE , F )
∝ φ0,1(t) · g
−K1 · t+K2 ·

αE
0
β
+ λu−K3
 · I[(αE , u−E) ∈ B]
= h(t, β, αE , u−E)
Then, as detailed below, we can generate samples from h(t, β, αE , u−E) sequentially by using Gibbs.
1. Initialization (k = 0): Initialize (t, β, αE , u−E) and denote them as (t(0), β(0), α
(0)
E , u
(0)
−E)
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2. Gibbs Update: At step k with variables (t(k), β(k), α
(k)
E , u
(k)
−E)
(a) Update t by sampling a proposal, denoted as τ (k+1), from a proposal distribution that is Normal
with mean τ (k) and variance a2k; ak represents the step size. The proposal distribution is symmetric
with an acceptance ratio of
r = min
(
h(t(k+1), β(k), α
(k)
E , u
(k)
−E)
h(t(k), β(k), α
(k)
E , u
(k)
−E)
, 1
)
Accept the proposal t(k+1) with probability r. Otherwise, set t(k+1) = t(k).
(b) Jointly update β and αE by sampling proposals, denoted as β
(k+1) and α
(k+1)
E , via
β(k+1) = β(k) + bk · ν1, ν1 ∼ G
α
(k+1)
E = sE · | |α(k)E |+ bn · ν2|, ν2 ∼ G|E|
Here, G denotes the distribution of the randomized term ω in the randomized sisVIVE and G|E|
denotes |E| i.i.d. distributions of G. The term bk represents the step size for our update. Both
proposals are also symmetric with an acceptance ratio r of
r = min
(
g(ω(t(k+1), β(k+1), α
(k+1)
E , u
(k)
−E))
g(ω(t(k+1), β(k), α
(k)
E , u
(k)
−E))
, 1
)
Accept β(k+1) and α
(k+1)
E with probability r. Otherwise, set β
(k+1) = β(k) and α
(k+1)
E = α
(k)
E .
(c) Update u
(k+1)
−E by sampling a value v from a truncated G distribution at ∆
−,∆+ where
∆− = ∆− λ1, ∆+ = ∆ + λ1, ∆ =
−K1 · t(k+1) +K2
α(k)E
β(k)
−K3

−E
and set u
(k+1)
−E =
1
λ (v −∆).
3. Stop when convergence criterion is reached after 5000 burn-in samples and return 10,000 samples of t.
We make a few remarks about the sampling algorithm. First, in practice, we initialize the sampler at the
observed values of the sampling variables: t(0) is set to be the observed TSLS test statistic t̂TSLS with
the selected instruments E, β(0), α
(0)
E , u
(0)
−E are set to be the solutions from the randomized sisVIVE as
β̂, α̂E , û−E . Second, if G is Laplacian, we typically tune the step sizes ak and bk to have acceptance rates
around 0.3. Third, if G is Gaussian, we can use a simpler hit-an-run sampling instead of Gibbs and bypass
the requirement to pick step sizes ak and bk; see Bi et al. (2017) for details.
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3.5 Inference via the Conditional Density Accounting for Instrument Selection
Once we obtain S samples of ti, i = 1, . . . , S from a sampling algorithm, such as the one described in Section
3.4, we can achieve the conditional inference goals laid out in Section 2.5. For example, let t̂TSLS be the
observed value of the test statistic from traditional MR analysis after selecting EC valid instruments from
sisVIVE. Instead of comparing this observed test statistic to a marginal null distribution to obtain a p-value,
we can now obtain a conditional p-value p(β0) of the null hypothesis of the exposure effect H0 : β
∗ = β0 by
using the N samples of t generated from the sampler.
p(β0) =
1
N
N∑
i=1
I(ti ≥ t̂TSLS)
If the significance level is set to pi, we can reject the null hypothesis if p(β0) < pi. For example, if β0 = 0
with (estimated) valid instruments EC and p(0) < pi, we can say that there is a significant exposure effect
after accounting for instrument selection done a priori. Also, by the duality between confidence intervals
and hypothesis testing, we can construct a 1 − pi conditional confidence interval for β∗ by retaining β0’s
where p(β0) ≥ pi. Because inverting hypothesis for every β0 can be computationally burdensome, we use an
importance sampling trick from Markovic and Taylor (2017) to improve computation; see the supplementary
materials for implementation details.
4 Simulation
We conduct a simulation study to demonstrate the proposed method. Formally, we generate data according
to model (1) with the following parameters: n = 1000, p = 10, |E∗| = 3, β∗ = 1, αj = 7 for j ∈ E∗,
Σ∗11 = Σ
∗
22 = 1, and Σ
∗
12 = 0.8. The instruments is generated according to standard multivariate Normal, i.e.
Zi ∼ N(0, IL). For the parameters of the procedure (9), we follow Markovic and Taylor (2017) and set λ =
2.01 ∗√n · log(n),  = 0.01. The randomization ω = (ω1, . . . , ωL) is taken as having independent Gaussian
components with the standard deviation (denoted as std) set to be 0.5∗ std(PZ
(
Z D
)
)∗ std(PZY)∗
√
n
n−1 .
First, we evaluate whether the null distribution of the conditional p-values is uniform; if the conditional
p-values are uniformly distributed, the conditional Type I error is controlled and consequently, the confidence
interval would have the desired conditional coverage. We do this for different values of γ∗ where γ∗j = r for
every j and r ranges from 0.04 to 2.5. For each γ∗, we plot the empirical cumulative distribution (CDF)
function of the conditional p-values under H0 : β
∗ = 1 and compare it with the uniform distribution to see
whether the two distributions are identical (i.e. line up along the 45 degree line). Figure 1 presents the
evaluation for the TSLS estimator. For TSLS, except for the case when the instrument is weak and r ≤ 0.06,
the distribution of the conditional p-values is close to uniform, aligning with what we expect from theory.
When the instruments are weak, the empirical distribution deviates from the uniform distribution and our
conditional inference suffers from weak instrument bias (Staiger and Stock, 1997; Stock et al., 2002).
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Second, we compare our confidence interval to the naive confidence interval that does not take instrument
selection into account, or mathematically treats E as fixed. Specifically, we compare the marginal coverage
rates of our interval and the naive interval when EC contains no invalid instruments. As described in Section
2.5, our 1− pi conditional confidence interval will have 1− pi marginal coverage under this case. In contrast,
the naive interval only provides 1− pi coverage if E is fixed and hence, will have lower than 1− pi coverage.
Like before, we plot (i) the empirical coverage rates and (ii) the average lengths as a function of r for the
proposed conditional interval and the naive confidence interval. Figure 2 presents the evaluation for the
test statistic based on the TSLS estimator. For TSLS, while the two intervals are very close, our interval is
always closer to the nominal level, set at 95% compared to the naive interval. Our interval also suffers from
weak instrument bias as it fails to achieve 95% coverage when r is very small, but not as drastic as the naive
interval. Figure 3 presents the same evaluation for TSLS, but when we have more candidate instruments to
select from (i.e. L = 100) and |E∗| = 30; everything else remains the same as before. Here, the effect of
instrument selection on coverage is more pronounced between the two intervals, with our interval achieving
closer to 95% coverage than the naive interval. In both cases, the effect from instrument selection on coverage
rates for the naive interval decreases as the instruments get stronger, but weak instruments can amplify the
selection effect.
We note that we only presented simulation studies where the naive interval has the “best chance” of doing
well compared to our interval. In the supplementary materials, we conduct more “idealized” simulation
studies where we design the data generating process so that the difference between our interval and the
naive interval is drastic, specifically by varying (i) the magnitude of the instruments’ invalidity via α∗E and
γ∗ associated with invalid instruments and (ii) the magnitude of endogeneity via Σ∗12. In summary, in finite
samples, our TSLS interval can maintain coverage from 80% to 96% depending on the instrument strength,
invalidity, and endogeneity, whereas the naive interval has coverage rates range from near 0% to 70% and
never reach the nominal 95% coverage level.
Also, in the supplementary materials, we repeat the two evaluations under different test statistics to
see how our inference procedure is affected by the choice of test statistics. In short, for the AR test, our
conditional method shows Type I error control for all values of instrument strength. Also, when comparing
coverage of the AR test, we observe that the differences are small, most likely due to the AR test being
generally conservative.
5 Extension: Summary Data in Mendelian Randomization
While our method was described where individual observations of Yi, Di, Zi were available, majority of MR
studies are based on summary statistics due to privacy and logistical reasons (Burgess et al., 2013; Pierce
and Burgess, 2013). The summary statistics are derived from GWAS and they typically consist of estimated
regression coefficients that measure the associations of genetic variants with various traits. In this section,
16
Figure 1: Comparison between the CDF of the empirical distribution of the conditional p-values using TSLS
statistic and the uniform distribution. r represents instrument strength as measured by setting γ∗j = r for
all j.
we extend our above method to summarized data common in a MR analysis.
Denote Z(j) as the j-th column of matrix Z. For each instrument j, let β̂j,Y be the estimated regression
coefficient from running a simple linear regression between Y and instrument Z(j) and let se
2(β̂j,Y ) be the
variance of the estimate β̂j,Y . Similarly, for each instrument j, let β̂j,D be the estimated regression coefficient
from running a simple linear regression between D and Z(j) and let se
2(β̂j,D) be the variance of the estimate
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Figure 2: Comparison between the naive and conditional CI using the TSLS test statistic when there are
L = 10 candidate instruments. The x-axis represents instrument strength as measured by setting γ∗j = r.
The left plot shows the empirical coverage rate of both intervals and the right plots show the average lengths
of both intervals.
Figure 3: Comparison between the naive and conditional CI using the TSLS test statistic when there are
L = 100 candidate instruments. The x-axis represents instrument strength as measured by setting γ∗j = r.
The left plot shows the empirical coverage rate of both intervals and the right plots show the average lengths
of both intervals.
β̂j,D. Lemma 7 shows that, under suitable assumptions, the statistics Z
ᵀY,ZᵀD,ZᵀZ that are critical in
the derivation of the conditional density in Section 3.2, can be derived with MR summary statistics,
Lemma 1. Suppose we have the summary statistics β̂j,Y , se
2(β̂j,Y ), β̂j,D, se
2(β̂j,D) and the data Y,D,Z
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follows the model in equation (1). If
(i) ZᵀZ is a diagonal, but not necessarily identity, matrix and
(ii) Y,D,Z are centered to mean zero,
the quantities ZᵀY, ZᵀD,ZᵀZ can be written as
Zᵀ(j)Z(j) =
(n− 1) · se2(β̂1,Y ) + β̂21,Y
(n− 1) · se2(β̂i,Y ) + β̂2i,Y
· c
Zᵀ(j)Y = β̂i,Y ·
(n− 1) · se2(β̂1,Y ) + β̂21,Y
(n− 1) · se2(β̂i,Y ) + β̂2i,Y
· c
Zᵀ(j)D = β̂i,D ·
(n− 1) · se2(β̂1,Y ) + β̂21,Y
(n− 1) · se2(β̂i,Y ) + β̂2i,Y
· c
where c is an unknown constant factor, i.e. they are known up to an unknown factor c.
Lemma 7 shows that under conditions (i) and (ii), we can rewrite the quantities ZᵀY, ZᵀD,ZᵀZ as
functions of the summary statistics, up to an unknown constant factor c; later, in Theorem 5, we show
that this unknown constant factor does not impact our inference procedure of β∗. The first condition (i) of
Lemma 7 requires that instruments are pairwise uncorrelated. This is a common assumption in summarized
MR data (cf. Section 2 of Bowden et al. (2017b) or Assumption 1 and Section 2.2 of Zhao et al. (2018b))
and is typically enforced by keeping the genetic distance between each instruments to be sufficiently large
and changing the clumping thresholding in software (Purcell et al., 2007; Hemani et al., 2018). The second
condition (ii) of Lemma 7 requires that the individual level data be centered, similar to many works on the
Lasso, including the instrument selection procedure analyzed by Windmeijer et al. (2016) (Section 5.1, page
7). We remark that from well-known properties of regression, summary statistics do not change when the
data is centered or not, and hence, (ii) is not an issue for summarized data from MR. Finally, we remark
that unlike typical MR methods which assume that the summary statistics of Y and D, specifically β̂j,Y and
β̂j,D, are independent (see Table 5 of Hartwig et al. (2017) for examples), we do not make this assumption
in our setting; in other words, our samples for the outcome and the exposure can overlap.
The following theorem states that if the conditions of Lemma 7 holds, then we can use summarized
statistics to obtain conditional null densities using the same method outlined above.
Theorem 2 (Inference with summarized data). Under the assumptions in Lemma 7, the conditional infer-
ence density in (22) is identical, regardless of the value of c.
6 Application
We demonstrate our method by studying the effect of adiposity, measured using the body mass index (BMI),
on diastolic blood pressure (DBP) using MR. A MR study by Timpson et al. (2009) reaffirmed many non-
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MR observational studies that there is a positive relationship between BMI and DBP, using two SNPs. Our
goal is to replicate this analysis by using the UK Biobank (Sudlow et al., 2015) and calibrate p-values and
confidence intervals for the exposure effect after selecting valid instruments via sisVIVE.
We consider a pool of p = 315 SNPs as instruments for BMI and DBP; these SNPs were originally
identified by Locke et al. (2015) and we extract the same set of SNPs in the UK Biobank with the software
MR-Base (Hemani et al., 2018). We use the standard defaults for MR-Base, which makes sure that the
instruments are far apart in the genome and they are sufficiently strong. We use the summary statistics
provided by MR-Base, specifically the OLS regression coefficient estimates and their standard errors between
each instrument and the treatment / outcome. Around 5% of individuals did not have both the treatment
and the outcome values recorded in the UK Biobank data, leading to slightly different sample sizes for the
instrument-treatment regression (n1 = 336, 107) and the instrument-outcome regression (n2 = 317, 756).
Because the difference in the sample sizes are small compared to the total sample size, we take the average
of the two samples n = 12 (n1 + n2) to be the effective sample size for our analysis.
We evaluate our method based on multiple choices of λ. In particular, unlike typical penalized regression
where this is chosen automatically with cross-validation, in the empirical analysis, we treat λ as a sensitivity
parameter where, roughly, a large λ would lead to more instruments being selected as valid. Based on
the result by Windmeijer et al. (2016) regarding sisVIVE, we only consider sequence of λs with selection
consistency, typically when the proportion of selected instruments is less than 50% of the total number of
instruments.
The results of our analysis is summarized in figure 4. We plot the TSLS estimate and the conditional
and naive confidence intervals as error bars of the TSLS estimator for different values of λ. We also denote
the number of instruments for each choice of λ. In general, the TSLS estimate is stable for different choices
of selected instruments where |E| < p/2 and agrees with previous analysis of the relationship between BMI
and blood pressure by Timpson et al. (2009). Also, the difference between conditional and naive intervals
is small for this dataset. This is most likely due to the fact that n is very large and well-known, strong
instruments were used, mitigating some of the selection effects. However, as noted before, the difference
between the naive and the conditional confidence interval can be large depending on the underlying data
generating process and more importantly, our conditional confidence interval has guaranteed marginal and
conditional coverage rate whereas the naive confidence interval does not.
7 Discussion
This work demonstrates a conditional approach to inference of the treatment effect after selecting plausibly
valid instruments by a data-driven selection method called sisVIVE. We show that our conditional p-values
and confidence intervals attain the nominal type I error and coverage rate, while the naive ones ignoring the
selection effect would perform worse in certain scenarios. We also demonstrate our method through a real
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dataset analysis. We believe our method can be useful whenever the analyst worries about possible presence
of invalid instruments and selection effects from choosing the “best” set of instruments.
Our approach outlined above can be extended to correct for the selection effect outside of sisVIVE. In
particular, our method can be applied to other instrument selection process as long as it is expressive as a
convex program (Bi et al., 2017). Also, based on the selective CLT, other model specifications are possible
as long as the test statistic of interest is asymptotically Gaussian. Finally, while we focused on applications
to MR, in the supplementary materials, we demonstrate an application of our method to development
economics.
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Figure 4: Analysis of the effect of BMI on blood pressure using the UK Biobank. The y-axis is the TSLS
estimates and the conditional and naive confidence intervals are plotted as error bars. The x-axis is the value
of λ and the number of the selected invalid instruments for each λ is attached on top of the each bar.
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SUPPLEMENTARY MATERIALS
Proofs: The file contains all the technical details, including review of model properties in the invalid IV
setting, all the proofs to the statements in the article, additional sampling strategy detail; other
simulation study and a developmental economics dataset study.
Python package: See the python software code on github: https://github.com/nanbi/Python-software/
tree/lasso_iv. It is branched from https://github.com/jonathan-taylor/selective-inference.
UK Biobank dataset: The dataset used in Section 14 can be freely obtained from here: http://app.
mrbase.org/ after agreeing to the data access agreement.
9 Review of Model Properties
9.1 Reduced-Form Model
Let E∗ = supp(α∗). The structural model can be rewritten as a reduced-form model where Y and D are
only functions of Z. This is achieved by substituting the expression for D in the model for Y and D
Yi = Z
ᵀ
i,E(α
∗
E∗ + γ
∗
E∗β
∗) + Zᵀi,−E∗γ−E∗β
∗ + ξi1
Di = Z
ᵀ
i γ
∗ + ξi2
The error terms for the reduced-form model, ξi1 and ξi2, are defined as ξi1 = i + δi2β
∗ and ξi2 = δi. The
two error terms follow a distribution (ξi1, ξi2)
i.i.d.∼ H(0,Ω∗) where Ω∗ is the covariance matrix
Ω∗ =
1 β∗
0 1
Σ∗
 1 0
β∗ 1

We note that the transformation between the covariance matrices Σ∗ and Ω∗ is invertible for any value of
β∗ since we can write Ω∗ as an invertible map of Σ∗ above.
9.2 Point Estimation for Model Parameters
Lemma 2 shows that the most popular estimators for β∗, the two-stage least squares (TSLS), consistently
estimates the treatment effect parameter β∗. We remark that the conditions in Lemma 2 are more general
than the model conditions in the main manuscript.
Lemma 2. Suppose Zᵀδ/n
p→ 0, Zᵀξ.2/n p→ 0, ZᵀZ/n p→ Λ where Λ is a non-singular matrix. For a set E
where E∗ ⊆ EC and γ∗E 6= 0, the stage least squares estimator (TSLS) βˆTSLS
βˆTSLS =
Dᵀ(PZ − PZE )Y
Dᵀ(PZ − PZE )D
(15)
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is consistent for β∗
Proof of Lemma 2. Pugging in the true model, it simplifies to
βˆTSLS =
Dᵀ(PZ − PZE )(Dβ∗ + ZEα∗E + δ)
Dᵀ(PZ − PZE )D
= β∗ +
Dᵀ(PZ − PZE )δ
Dᵀ(PZ − PZE )D
Now decompose the projection matrix PZ −PZE as a new projection matrix PW where W is a matrix whose
columns represent a L− |E| basis vectors of the column space Z−E adjusted by PZE .
1√
n
Dᵀ(PZ − PZE )δ =
1√
n
Dᵀ(W (W ᵀW )−1W ᵀ)δ
=
1
n
DᵀW
(
W ᵀW
n
)−1
1√
n
W ᵀδ
→ E(DiW ᵀi )E(WiW ᵀi )−1
1√
n
W ᵀδ
→ E(DiW ᵀi )E(WiW ᵀi )−1 ·N(0, E(WiW ᵀi )Σ∗11)
= N(0,Σ∗11E(DiW
ᵀ
i )E(WiW
ᵀ
i )
−1E(DiWi))
1
n
Dᵀ(PZ − PZE )D =
1
n
DᵀW
(
W ᵀW
n
)
W ᵀD
n
→ E(DiW ᵀi )E(WiW ᵀi )E(DiW ᵀi )
we finally have
√
n(βˆTSLS − β∗)→ N(0, Σ
∗
11
E(DiW
ᵀ
i )E(WiW
ᵀ
i )E(DiW
ᵀ
i )
)
which gives the consistency result.
Lemma 3. Suppose Zᵀδ/n
p→ 0, Zᵀξ.2/n p→ 0 and ZᵀZ/n p→ Λ where Λ is a non-singular matrix. Then,
under the null hypothesis H0 : β
∗ = β0, the estimator Σˆ(β0)
Σˆ(β0) =
1
n
(Y −Dβ0)ᵀ
Dᵀ
PZ⊥ (Y −Dβ0 D) (16)
is consistent for Σ∗. Also, the estimator Ωˆ(β0)
Ωˆ(β0) =
1 β0
0 1
 Σˆ
 1 0
β0 1
 (17)
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is consistent for Ω∗.
Proof of Lemma 3. Under the null hypothesis H0 : β
∗ = β0, we have
Σˆ11(β0) =
‖PZ⊥(Y −Dβ0)‖22
n
=
‖PZ⊥(Zα∗ + δ)‖22
n
=
δᵀδ
n
− δ
ᵀZ
n
(
ZᵀZ
n
)−1
Zᵀδ
n
Σˆ12(β0) =
(Zγ∗ + ξ.2)ᵀPZ⊥(Zα∗ + δ)
n
=
ξᵀ.2PZ⊥δ
n
=
ξᵀ.2δ
n
− ξ
ᵀ
.2Z
n
(
ZᵀZ
n
)−1
Zᵀδ
n
Σˆ22(β0) =
(Zα∗ + ξ.2)ᵀPZ⊥(Zα∗ + ξ.2)
n
=
ξᵀ.2PZ⊥ξ.2
n
=
ξᵀ.2ξ.2
n
− ξ
ᵀ
.2Z
n
(
ZᵀZ
n
)−1
Zᵀξ.2
n
By the law of large numbers, δᵀδ/n
p→ Σ∗11, ξᵀ.2δ/n
p→ Σ∗12, and ξᵀ.2ξ.2/n
p→ Σ∗22. Also, by the assumed
limiting properties of ZᵀZ, Zᵀδ, and Zᵀξ.2, we arrive at the consistent estimator of Σ∗.
To prove Ωˆ(β0) is a consistent estimator of Ω
∗, we simply apply Slutsky’s theorem to Σˆ(β0) to obtain
the desired result.
Lemma 4. Under the same conditions as lemma 3, the estimator Σˆ(βˆTSLS)
Σˆ(βˆTSLS) =
1
n
(Y −DβˆTSLS)ᵀ
Dᵀ
PZ⊥ (Y −DβˆTSLS D)
is consistent for Σ∗. This also implies that under the null, the estimator Ωˆ(βˆTSLS)
Ωˆ(βˆTSLS) =
1 βˆTSLS
0 1
 Σˆ
 1 0
βˆTSLS 1

is consistent for Ω∗.
Proof of Lemma 4. To prove Σˆ(βˆTSLS) is a consistent estimator of Σ
∗, we apply Slutsky’s theorem to Σˆ(β0)
together with the fact that βˆTSLS is consistent for β0 to obtain the desired result.
Again by Slutsky’s theorem on the consistency of Σˆ(βˆTSLS) we get the consistency of Ωˆ(βˆTSLS) for
Ω∗.
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10 Proofs of the Conditional Densities
10.1 Exact Conditional Density
Theorem 3 (Exact conditional density via reparametrization). The conditional density of Y,D, ω can be
expressed (up to a proportionality constant) with respect to the variables Y,D, β, αE , u−E, i.e.
`(Y,D, ω | supp(α) = E, sign(αE) = ŝE)
∝f(Y,D) · g
−
 Dᵀ
Zᵀ
PZ(Y − Zα−Dβ) + λ
 u
0
+ 
 α
β
 · |J | · I(B) (18)
where
|J | = det
DᵀPZD DᵀZE
ZᵀED Z
ᵀ
EZE
+ I
 · λ|−E|
B = {sign(αE) = ŝE , α−E = 0, uE = ŝE , ‖u−E‖∞ ≤ 1}
Proof of Theorem 3. First, we can construct the reparametrization map from KKT condition
ω = −
 Dᵀ
Zᵀ
PZ(Y − Zα−Dβ) + λ
 u
0
+ 
 α
β

such that
sign(αE) = uE = ŝE, α−E = 0, ||u||∞ ≤ 1
Second, we compute the Jacobian of this mapping (Y,D, ω)→ (Y,D, β, αE , u−E):
|J | =
∣∣∣∣ ∂(Y,D, ω)∂(Y,D, β, αE , u−E)
∣∣∣∣ = ∣∣∣∣ ∂ω∂(β, αE , u−E)
∣∣∣∣
= det

DᵀPZD +  DᵀZE 0
ZᵀED Z
ᵀ
EZE + I|E|×|E| 0
Zᵀ−ED Z
ᵀ
−EZE λI|−E|×|−E|

= det
 DᵀPZD DᵀZE
ZᵀED Z
ᵀ
EZE
+ I(1+|E|)×(1+|E|)
 · λ|−E|
Then, using the change of variables formula, the density of (Y,D, ω) can be equivalently expressed with
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variables (Y,D, β, αE , u−E) (where f(Y,D) denotes the pre-selection distribution of data)
`(Y,D, ω | supp(α) = E, sign(αE) = ŝE)
=f(Y,D) · g(ω) · I(supp(α) = E, sign(αE) = ŝE)
=f(Y,D) · g
−
 Dᵀ
Zᵀ
PZ(Y − Zα−Dβ) + λ
 u
0
+ 
 α
β
 · |J | · I(B)
where for the last line, the conditioning event {supp(α) = E, sign(αE) = ŝE} is equivalent to the event B
under the new parametrization by the optimization variables.
10.2 Asymptotic Conditional Densities with Selective CLT
For brevity we directly describe the Selective CLT in our model and the sisVIVE procedure.
Consider any test statistic T for β∗ and let S be defined as part of the score of the loss function in
sisVIVE:
S =
 ZᵀY
DᵀPZY

Suppose for any fixed E and under the null H0 : β
∗ = β0, T and 1√nS jointly converge to a Normal
distribution  T
1√
n
S
→ N
µT
µS
 ,
 ΣT ΣT,S
ΣT,S ΣS
 , n→∞ (19)
If ΣT and ΣT,S are known, by the joint gaussianity of T and S, we can express S into mutually orthogonal
parts, F and ΣS,TΣ
−1
T T where these two terms are independent of each other
S = F + ΣS,TΣ
−1
T T
F =
 ZᵀY
DᵀPZY
− ΣS,TΣ−1T T
Also, by the joint gaussianity, F is, in the asymptotic sense, a sufficient statistic for µS and by standard
arguments for exponential families, conditioning on F in the conditional density (18) will lead to a free-of-µS
density, i.e.
`H0(T, ω | supp(α) = E, sign(αE) = ŝE , F ) = φ(µT ,ΣT )(T ) · g(T, β, α, u | E, ŝE , F ) · |J | · I(B) (20)
where φ(µT ,ΣT ) is the density of the Normal distribution with mean µT and variance ΣT . Intuitively, the
terms on the right hand side of φ(µT ,ΣT )(T ) in (20) reflect that the effect that instrument selection has on
the unconditional density of the test statistic φ(µT ,ΣT )(T ), similar to the terms on the right hand size of
f(Y,D) in (18). But, (20) is easier to sample from than (18) because by conditioning on F , the (20) is only
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function of parameters µT ,ΣT , which are known from the null distribution of the test statistic T . Also, if
L(T | E, ŝE , F ) is the distribution of T from (20) by marginalizing out ω, then Markovic and Taylor (2017)
has proved under regularity conditions, the p-value based on L(T | E, ŝE , F ) is uniformly distributed under
H0 and thus, with the conditioning of F , we obtain a pivotal density to sample from. Importantly, the result
still holds under regularity conditions if we replace the unknown ΣT and ΣT,S with consistent estimators of
them (Tian and Taylor, 2016); see the next section for specific instances of T being the TSLS and the AR
test statistics.
10.3 Asymptotic Conditional Densities with TSLS Statistics
To discriminate from the random variables, we explicitly use the supscription obs to denote the observed
values plugged in from the dataset.
There are several preparation steps regarding the components in the conditional density and theorem 4
combines them to finally arrive at the conditional density for sampling. Lemma 5 points out the components
in TTSLS that determines its asymptotic behavior. Lemma 6 deals with the asymptotics of the score vector
in the KKT condition.
Lemma 5. Assuming Σˆ11 is consistent estimator that Σˆ11 = Σ
∗
11 +Op(1), then
TTSLS =
[
DᵀZ(ZᵀZ)−1√
Σˆ11
√
Dᵀ(PZ − PZE )D
]obs
· (Zᵀδ)−
[
DᵀZE(Z
ᵀ
EZE)
−1√
Σˆ11
√
Dᵀ(PZ − PZE )D
]obs
· (ZᵀEδ) +Op(1) (21)
Lemma 6. The reconstruction map is asymptotically equivalent to
ω =
 ZᵀZ ZᵀD
(ZᵀD)ᵀ DᵀPZD
obsα− α∗
β − β∗
−
 I
(ZᵀD)ᵀ(ZᵀZ)−1
obs · Zᵀδ + λ
u
0
+ 
α
β
+Op(1)
We can see that the term Zᵀδ dictates the asymptotic behavior of both the test statistic and the KKT
condition, which essentially allows us to have a linear decomposition with explicit parametric expression.
Theorem 4 gives the final conditional density using the test statistic TTSLS that is feasible to sampling.
Theorem 4 (Asymptotic conditional density of TSLS test statistic). The asymptotic conditional density of
TTSLS under the null hypothesis H0 : β
∗ = β0 can be expressed (up to a proportionality constant) with respect
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to the variables TTSLS, β, αE , u−E:
`β0(TTSLS, ω | supp(α) = E, sign(αE) = ŝE , F ) ∝ φ(0,1)(TTSLS)
· g
−ΣobsS,T · TTSLS +
ZᵀZ ZᵀD
DᵀZ DᵀPZD
+  · I
obsα
β
+ λ
u
0
−
 ZᵀY
DᵀPZY
− ΣS,T · T̂TSLS
obs

· |J |obs · I(B)
(22)
where
ΣS,T =
√
Σˆ11
Dᵀ(PZ − PZE )D
Zᵀ(PZ − PZE )D
Dᵀ(PZ − PZE )D

We remark that Σ∗12, i.e. the correlation between D and δ does not show up in the conditional density.
We can also use the TSLS estimator in the conditional density instead of the TSLS test statistic. They are
essentially equivalent asymptotically in the inference. The test statistic TTSLS(β0) and the point estimator
βTSLS are related as follows:
TTSLS(β0) =
βTSLS − β0√
Σ∗11
Dᵀ(PZ−PZE )D
Corollary 1 (Asymptotic conditional density of TSLS estimator). The asymptotic conditional density of
βTSLS under the null hypothesis H0 : β
∗ = β0 can be expressed (up to a proportionality constant) with respect
to the variables βTSLS, β, αE , u−E:
`β0(βTSLS, ω | supp(α) = E, sign(αE) = ŝE , F ) ∝ φ(β0,ΣobsT )(βTSLS)
· g
−ΣobsS,T · Σ−1,obsT · βTSLS +
ZᵀZ ZᵀD
DᵀZ DᵀPZD
+  · I
obsα
β
+ λ
u
0
−
 ZᵀY
DᵀPZY
− ΣS,TΣ−1,obsT β̂TSLS
obs

· |J |obs · I(B)
(23)
where
ΣT =
Σˆ11
Dᵀ(PZ − PZE )D
, ΣS,T =
Σˆ11
Dᵀ(PZ − PZE )D
Zᵀ(PZ − PZE )D
Dᵀ(PZ − PZE )D

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Proof of Lemma 5. Notice we have
TTSLS(β0) =
Dᵀ(PZ − PZE )(Y −Dβ0)√
Σˆ11
√
Dᵀ(PZ − PZE )D
=
Dᵀ(PZ − PZE )δ√
Σˆ11 ·
√
Dᵀ(PZ − PZE )D
=
1√
n
Dᵀ(PZ − PZE )δ√
Σˆ11 ·
√
1
nD
ᵀ(PZ − PZE )D
where the second line is by plugging in the true model.
Let us denote for simplification the quadratic terms
Aˆ =
ZᵀZ
n
, AˆE =
ZᵀEZE
n
, Bˆ =
ZᵀD
n
, BˆE =
ZᵀED
n
and their asymptotic means all exist
A = E(Zi · Zᵀi ), AE = E(Zi,E · Zᵀi,E), B = E(Zi ·D), BE = E(Zi,E ·D)
we know that
Aˆ = A+Op(n
− 12 ), AˆE = AE +Op(n−
1
2 ), Bˆ = B +Op(n
− 12 ), BˆE = BE +Op(n−
1
2 )
Now the numerator
1√
n
Dᵀ(PZ − PZE )δ
=
1√
n
(ZᵀD)ᵀ(ZᵀZ)−1(Zᵀδ)− 1√
n
(ZᵀED)
ᵀ(ZᵀEZE)
−1(ZEδ)
= (ZᵀD)ᵀ(ZᵀZ)−1 · 1√
n
(Zᵀδ)− (ZᵀED)ᵀ(ZᵀEZE)−1 ·
1√
n
(ZᵀEδ)
= BᵀA−1 · 1√
n
(Zᵀδ)−BᵀA−1E ·
1√
n
(ZᵀEδ) + (Bˆ
ᵀAˆ−1 −BᵀA−1) · 1√
n
(Zᵀδ) + (BˆᵀAˆ−1E −BᵀA−1E ) ·
1√
n
(ZᵀEδ)
= BᵀA−1 · 1√
n
(Zᵀδ)−BᵀA−1E ·
1√
n
(ZᵀEδ) +Op(n
− 12 )
where the last equation has used the fact that
Aˆ−1 = A−1 +Op(n−
1
2 ), Aˆ−1E = A
−1
E +Op(n
− 12 )
and that
BˆᵀAˆ−1 = BᵀA−1 +Op(n−
1
2 ), BˆᵀAˆ−1E = B
ᵀA−1E +Op(n
− 12 )
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from delta method, and also
1√
n
(Zᵀδ) = Op(1)
from standard central limit theorem since E(Zᵀδ) = 0 under the model assumption.
The denominator serves as the normalizing factor with similar argument
√
Σˆ11
√
1
n
Dᵀ(PZ − PZE )D = (
√
Σ∗11 + op(1))
√
1
n
(ZᵀD)ᵀ(ZᵀZ)−1(ZᵀD)− 1
n
(ZᵀED)
ᵀ(ZᵀEZE)(Z
ᵀ
ED)
= (
√
Σ∗11 + op(1))
√
BˆᵀAˆ−1Bˆ − BˆᵀEAˆ−1E BˆE
= (
√
Σ∗11 + op(1)) · (
√
BᵀA−1B −BᵀEA−1E BE + op(1))
=
√
Σ∗11
√
BᵀA−1B −BᵀEA−1E BE + op(1)
Therefore the test statistic is asymptotically
TTSLS(β0) =
BᵀA−1√
Σ∗11
√
BᵀA−1B −BᵀEA−1E BE
1√
n
· (Zᵀδ)− B
ᵀA−1E√
Σ∗11
√
BᵀA−1B −BᵀEA−1E BE
1√
n
· (ZᵀEδ) + op(1)
=
[
DᵀZ(ZᵀZ)−1√
Σˆ11
√
Dᵀ(PZ − PZE )D
]obs
· (Zᵀδ)−
[
DᵀZE(Z
ᵀ
EZE)
−1√
Σˆ11
√
Dᵀ(PZ − PZE )D
]obs
· (ZᵀEδ) + op(1)
The second line follows from the same argument replacing the sampling variables Aˆ with the observed values[
ZᵀZ
n
]obs
, i.e.
[
ZᵀZ
n
]obs
= A+Op(n
− 12 ), and with AˆE , Bˆ, BˆE .
Proof of Lemma 6. We start from the KKT condition
ω =
Zᵀ
Dᵀ
PZ (Z D)
α
β
−
Zᵀ
Dᵀ
PZY + λ
u
0
+ 
α
β

=
 ZᵀZ ZᵀD
(ZᵀD)ᵀ DᵀPZD
α− α∗
β − β∗
−
 Zᵀδ
DᵀPZδ
+ λ
u
0
+ 
α
β

= n
 A B
Bᵀ BᵀA−1B
 ·
α− α∗
β − β∗
−
 I
BᵀA−1
 · Zᵀδ + λ
u
0
+ 
α
β

+
 ZᵀZ − nA ZᵀD − nB
(ZᵀD)ᵀ − nBᵀ DᵀPZD − nBᵀA−1B
α− α∗
β − β∗
−
 0
(ZᵀD)ᵀ(ZᵀZ)−1 −BᵀA−1
 · Zᵀδ
= n
 A B
Bᵀ BᵀA−1B
 ·
α− α∗
β − β∗
−
 I
BᵀA−1
 · Zᵀδ + λ
u
0
+ 
α
β
+Op(1)−Op(1)
= n
 A B
Bᵀ BᵀA−1B
 ·
α− α∗
β − β∗
−
 I
BᵀA−1
 · Zᵀδ + λ
u
0
+ 
α
β
+Op(1)
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where the second line is by plugging in the model.
Now consider both sides of the second line. We choose the randomization with scale ω ∼ N(0, n · I),
hence ω = Op(n
1
2 ). We know λ
u
0
 and 
α
β
 are both of order Op(n 12 ) from the way we set λ and  and
that 1√
n
Zᵀδ = O(1). Comparing the density of both sides of the 2nd equation, we know it has to be true
that
√
n(α− α∗),√n(β − β∗) = O(1).
Reorganizing terms gives the third line, and according to the asymptotic arguments above we get to the
4th line.
The same argument replacing the sampling variables with the observed values gives us the desired result.
Proof of Theorem 4. From lemma 6 denote
TTSLS =
[
DᵀZ(ZᵀZ)−1√
Σˆ11
√
Dᵀ(PZ − PZE )D
]obs
· (Zᵀδ)−
[
DᵀZE(Z
ᵀ
EZE)
−1√
Σˆ11
√
Dᵀ(PZ − PZE )D
]obs
· (ZᵀEδ) + op(1)
d
= C1 · Zᵀδ − C2 · ZᵀEδ + op(1)
and we know its pre-selection asymptotic distribution is gaussian with µT = 0,ΣT = 1. The data vector is
the part S in the KKT condition , i.e.
S =
 I
(ZᵀD)ᵀ(ZᵀZ)−1
obs · Zᵀδ +Op(1)
d
= C3 · Zᵀδ +Op(1)
or that
1√
n
S = C3 · Zᵀδ + op(1)
therefore we see that (TTSLS ,
1√
n
S) is asymptotically jointly gaussian, and direct computation gives
ΣS,T = Cov(C3 · Zᵀδ, C1 · Zᵀδ − C2 · ZᵀEδ)
= E ([C3 · Zᵀδ] · [C1 · Zᵀδ − C2 · ZᵀEδ])− E(C3 · Zᵀδ) · E(C1 · Zᵀδ − C2 · ZᵀEδ)
= E ([C3 · Zᵀδ] · [C1 · Zᵀδ − C2 · ZᵀEδ] | Z)− E ((C3 · Zᵀδ) | Z) · E ((C1 · Zᵀδ − C2 · ZᵀEδ) | Z)
= Σ11 ∗ C3 · C1 · E(ZᵀZ)− Σ11 ∗ C3 · C2 · E(ZᵀZE)− 0
=
√
Σˆ11
Dᵀ(PZ − PZE )D
Zᵀ(PZ − PZE )D
Dᵀ(PZ − PZE )D

where for the second to last line with large sample size we can plug in ZᵀZ and ZᵀZE for the expectations
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and get rid of the difference because
ZᵀZ = E(ZᵀZ) +Op(
√
n)
ZᵀZE = E(ZᵀZE) +Op(
√
n)
and finally get to the last line.
Now start from lemma 6 and apply the linear decomposition technique with our (T, S) to derive the
asymptotic version of KKT condition
ω =
 ZᵀZ ZᵀD
(ZᵀD)ᵀ DᵀPZD
obsα− α∗
β − β∗
−
 I
(ZᵀD)ᵀ(ZᵀZ)−1
obs · Zᵀδ + λ
u
0
+ 
α
β

= −ΣobsS,T · T +
 ZᵀZ ZᵀD
(ZᵀD)ᵀ DᵀPZD
obsα− α∗
β − β∗
+ λ
u
0
+ 
α
β
−
 I
DᵀZ(ZᵀZ)−1
 · Zᵀδ − ΣS,T · T
obs
= −ΣobsS,T · T +

ZᵀZ ZᵀD
DᵀZ DᵀPZD
obs +  · I
 ·
α
β
+ λ
u
0
−
 I
DᵀZ(ZᵀZ)−1
 · ZᵀY − ΣS,T · T
obs
where in the last line to re-combine the terms with α∗ and β∗ with the observed values δ which gives back
the observed Y . This gives the reparametrization mapping (T, ω) → (T, αE , β, u−E). Since it is linear and
the coefficient matrices are fixed values and the Jacobian is constant.
Combining the above steps and from standard change-of-variable formula we obtain the conditional
sampling density of (T, α, β, u−E) as
`β0(T, α, β, u−E | supp(αˆ) = E, sign(αˆE) = sE)
∝ φ0,1(T ) · g
−ΣobsS,T · T +

ZᵀZ ZᵀD
DᵀZ DᵀPZD
obs +  · I
 ·
α
β
+ λ
u
0
−
 I
DᵀZ(ZᵀZ)−1
 · ZᵀY − ΣS,T · T
obs

Proof of Corollary 1. The logic of the proof is similar to theorem 4.
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The TSLS estimator
βTSLS =
Dᵀ(PZ − PZE )Y
Dᵀ(PZ − PZE )D
= β0 +
Dᵀ(PZ − PZE )δ
Dᵀ(PZ − PZE )D
= β0 +
(
DᵀZ(ZᵀZ)−1
Dᵀ(PZ − PZE )D
)
· (Zᵀδ)−
(
DᵀZE(Z
ᵀ
EZE)
−1
Dᵀ(PZ − PZE )D
)
· (ZᵀEδ)
= β0 +
(
DᵀZ√
n
(Z
ᵀZ√
n
)−1
DᵀZ√
n
(Z
ᵀZ√
n
)−1 ZᵀD√
n
)
· (Z
ᵀδ√
n
)−
 DᵀZE√n (ZᵀEZE√n )−1
DᵀZ√
n
(Z
ᵀZ√
n
)−1 ZᵀD√
n
 · (ZᵀEδ√
n
)
= β0 +

(
DᵀZ√
n
(Z
ᵀZ√
n
)−1
DᵀZ√
n
(Z
ᵀZ√
n
)−1 ZᵀD√
n
)obs
+Op(
1√
n
)
 · (Zᵀδ√n )−

 DᵀZE√n (ZᵀEZE√n )−1
DᵀZ√
n
(Z
ᵀZ√
n
)−1 ZᵀD√
n
obs +Op( 1√
n
)
 · (Z
ᵀ
Eδ√
n
)
≈ β0 +
(
DᵀZ(ZᵀZ)−1
Dᵀ(PZ − PZE )D
)obs
· (Zᵀδ)−
(
DᵀZE(Z
ᵀ
EZE)
−1
Dᵀ(PZ − PZE )D
)obs
· (ZᵀEδ)
d
= β0 + C1 · (Zᵀδ)− C2 · (ZᵀEδ)
where the asymptotic argument to plug in the observed values is the same as the proof for lemma 4 without
Σˆ11 in the denominators of the terms.
From this last line and the fact that
Zᵀδ√
n
→ N(0,Σ∗11 · E(Zᵀi Zi))
ZᵀEδ√
n
→ N(0,Σ∗11 · E(Zᵀi,EZi,E))
Cov(
Zᵀδ√
n
,
ZᵀEδ√
n
) = Σ∗11 · E(Zᵀi Zi,E)
we can derive that the pre-selection asymptotic distribution of βTSLS is gaussian with mean
µT = β0
and approximate variance
ΣT =
Σ∗11
Dᵀ(PZ − PZE )D
With the same KKT condition as in lemma 6
ω =
 ZᵀZ ZᵀD
(ZᵀD)ᵀ DᵀPZD
obsα− α∗
β − β∗
−
 I
(ZᵀD)ᵀ(ZᵀZ)−1
obs · Zᵀδ + λ
u
0
+ 
α
β

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and the same data vector
S =
 I
(ZᵀD)ᵀ(ZᵀZ)−1
obs · Zᵀδ
d
= C3 · Zᵀδ
and similar as in the proof of theorem 4 it can be seen that (βTSLS ,
1√
n
S) is asymptotically jointly
gaussian and to derive
ΣS,T = Cov(C3 · Zᵀδ, β0 + C1 · Zᵀδ − C2 · ZᵀEδ)
= E ([C3 · Zᵀδ] · [C1 · Zᵀδ − C2 · ZᵀEδ])− E(C3 · Zᵀδ) · E(C1 · Zᵀδ − C2 · ZᵀEδ)
= E ([C3 · Zᵀδ] · [C1 · Zᵀδ − C2 · ZᵀEδ] | Z)− E ((C3 · Zᵀδ) | Z) · E ((C1 · Zᵀδ − C2 · ZᵀEδ) | Z)
= Σ11 ∗ C3 · C1 · E(ZᵀZ)− Σ11 ∗ C3 · C2 · E(ZᵀZE)− 0
=
Σ∗11
Dᵀ(PZ − PZE )D
Zᵀ(PZ − PZE )D
Dᵀ(PZ − PZE )D

Again with linear decomposition we will get to a linear reparametrization mapping (βTSLS, ω)→ (βTSLS, αE , β, u−E)
with constant coefficient matrices and hence a constant Jacobian:
ω =
 ZᵀZ ZᵀD
(ZᵀD)ᵀ DᵀPZD
obsα− α∗
β − β∗
−
 I
(ZᵀD)ᵀ(ZᵀZ)−1
obs · Zᵀδ + λ
u
0
+ 
α
β

= −ΣobsS,TΣ−1,obsT · βTSLS +

ZᵀZ ZᵀD
DᵀZ DᵀPZD
obs +  · I
 ·
α
β
+ λ
u
0

−
 I
DᵀZ(ZᵀZ)−1
 · ZᵀY − ΣS,T · βTSLS
obs
Finally we obtain the conditional sampling density as
`β0(βTSLS, ω | supp(α) = E, sign(αE) = ŝE , F ) ∝ φ(β0,ΣobsT )(βTSLS)
· g
−ΣobsS,T · Σ−1,obsT · βTSLS +
ZᵀZ ZᵀD
DᵀZ DᵀPZD
+  · I
obsα
β
+ λ
u
0
−
 ZᵀY
DᵀPZY
− ΣS,TΣ−1,obsT β̂TSLS
obs

· |J |obs · I(B)
(24)
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10.4 Asymptotic Conditional Density with AR Test Statistic
Corollary 2 (Asymptotic conditional distribution of sampling target). The asymptotic conditional density
of T˜ under the null hypothesis H0 : β
∗ = β0 can be expressed (up to a proportionality constant) with respect
to the variables T˜ , β, αE , u−E:
`β0(T˜ , ω | supp(α) = E, sign(αE) = ŝE , F ) ∝ φ(0,ΣobsT )(T˜ )
· g
−ΣobsS,TΣ−1,obsT · T˜ +
ZᵀZ ZᵀD
DᵀZ DᵀPZD
+  · I
obsα
β
+ λ
u
0
−
 ZᵀY
DᵀPZY
− ΣS,TΣ−1T · T˜
obs

· |J |obs · I(B)
(25)
where
ΣT = Σˆ11 · Zᵀ(I − PZE )Z, ΣS,T = Σˆ11 ·
Zᵀ(I − PZE )Z
Dᵀ(I − PZE )Z

Remark 10.1 (Sampling for AR statistic). Given samples of the above sampling target {T˜i}i=1,...,N , we can
obtain the samples of the Anderson-Rubin test statistic {TAR,i}i=1,...,N of the conditional density via
TAR =
T˜ ᵀ · (ZᵀZ)−1 · T˜ /(p− |E|)
[(Y −Dβ0)ᵀ · (I − PZ) · (Y −Dβ0)]obs /(n− p)
(26)
Proof of Corollary 2. The sampling target is
T˜1×p = Zᵀ(I − PZE )(Y −Dβ0)
= Zᵀ(I − PZE )δ
= Zᵀδ − (ZᵀZE)(ZᵀEZE)−1ZᵀEδ
=
√
n
{
Zᵀδ√
n
− (Z
ᵀZE√
n
)(
ZᵀEZE√
n
)−1
ZᵀEδ√
n
}
=
√
n
{
Zᵀδ√
n
−
[(
(
ZᵀZE√
n
)(
ZᵀEZE√
n
)−1
)obs
+Op(1)
]
ZᵀEδ√
n
}
≈ Zᵀδ − ((ZᵀZE)(ZᵀEZE)−1)obs · ZᵀEδ
d
= C1(Z
ᵀδ)− C2(ZᵀEδ)
where again with the same asymptotic argument as in the proof for lemma 5 we plug in the observed values
and treat the coefficient C2 as constant.
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From this last line and the fact that
Zᵀδ√
n
→ N(0,Σ∗11 · E(Zᵀi Zi))
ZᵀEδ√
n
→ N(0,Σ∗11 · E(Zᵀi,EZi,E))
Cov(
Zᵀδ√
n
,
ZᵀEδ√
n
) = Σ∗11 · E(Zᵀi Zi,E)
we derive the pre-selection asymptotic distribution of T˜ is gaussian with mean
µT = 0
and approximate variance
ΣT = Σ
∗
11 · Zᵀ(I − PZE )Z
With the same KKT condition as in lemma 6
ω =
 ZᵀZ ZᵀD
(ZᵀD)ᵀ DᵀPZD
obsα− α∗
β − β∗
−
 I
(ZᵀD)ᵀ(ZᵀZ)−1
obs · Zᵀδ + λ
u
0
+ 
α
β

and the same data vector
S =
 I
(ZᵀD)ᵀ(ZᵀZ)−1
obs · Zᵀδ
d
= C3 · Zᵀδ
and similar as in the proof of theorem 4 we see that (T˜ , 1√
n
S) is asymptotically jointly gaussian and to derive
the covariance
ΣS,T = Σ
∗
11 ·
Zᵀ(I − PZE )Z
Dᵀ(I − PZE )Z

With linear decomposition we obtain a linear reparametrization mapping (T˜ , ω) → (T˜ , αE , β, u−E) with
constant coefficient matrices and hence a constant Jacobian term. Eventually the conditional sampling
density of the sampling target T˜ is
`β0(T˜ , ω | supp(α) = E, sign(αE) = ŝE , F ) ∝ φ[0,Σ̂11·Zᵀ(I−PZE )Z](T˜ )
· g
−ΣobsS,TΣ−1,obsT T˜ +
ZᵀZ ZᵀD
DᵀZ DᵀPZD
obsα
β
−
 I
(ZᵀD)ᵀ(ZᵀZ)−1
 · ZᵀY − ΣS,TΣ−1T T˜
obs + λ
u
0
+ 
α
β


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Proof of Remark 10.1.
TAR(β0) =
(Y −Dβ0)ᵀ(PZ − PZE )(Y −Dβ0)/(p− |E|)
(Y −Dβ0)ᵀPZ⊥(Y −Dβ0)/(n− p)
≈ (Y −Dβ0)
ᵀ(PZ − PZE )(Y −Dβ0)/(p− |E|)
((Y −Dβ0)ᵀPZ⊥(Y −Dβ0))obs /(n− p)
=
T˜ ᵀ · (ZᵀZ)−1 · T˜ /(p− |E|)
((Y −Dβ0)ᵀPZ⊥(Y −Dβ0))obs /(n− p)
where in the second line we used the fact that
(Y −Dβ0)ᵀPZ⊥(Y −Dβ0)/(n− p) =
(
E [(Y −Dβ0)ᵀPZ⊥(Y −Dβ0)] +Op(
√
n)
)
/(n− p)
((Y −Dβ0)ᵀPZ⊥(Y −Dβ0))obs /(n− p) =
(
E [(Y −Dβ0)ᵀPZ⊥(Y −Dβ0)] +Op(
√
n)
)
/(n− p)
and hence we can essentially plug in the observed value for the denominator.
11 Sampling Strategy for Confidence Intervals
11.1 TSLS Statistic
We first sample (ti, αi, βi, u−E,i)Ni=1 at the reference value β
r = β̂TSLS , and then to estimate the pivot at an
arbitrary β0 via importance sampling:
pivot(β0) =
∑N
i=1 I[ti ≤ T obsβ0 ] · w(ti, αi, βi, u−E,i)∑N
i=1 w(ti, αi, βi, u−E,i)
where
w(ti, αi, βi, u−E,i) =
`β0(ti, αi, βi, u−E,i)
`βr (ti, αi, βi, u−E,i)
=
g(ti, αi, βi, u−E,i, β0)
g(ti, αi, βi, u−E,i, βr)
We use binary search to find the values βU and βL such that pivot(βU ) = α/2 and pivot(βL) = 1−α/2 and
the confidence interval will be (βL, βU ).
11.2 TSLS Estimator
Same importance sampling approach as above but we use βTSLS as the sampling variable.We first sample
(ti, αi, βi, u−E,i)Ni=1 at the reference value (the observed) β
r = β̂TSLS , and then to estimate the pivot at an
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arbitrary β0 via importance sampling:
pivot(β0) =
∑N
i=1 I[ti ≤ T obsβ0 ] · w(ti, αi, βi, u−E,i)∑N
i=1 w(ti, αi, βi, u−E,i)
where
w(ti, αi, βi, u−E,i) =
`β0(ti, αi, βi, u−E,i)
`βr (ti, αi, βi, u−E,i)
=
φ
β0,
Σ̂11
Dᵀ(PZ−PZE )D
(ti)
φ
βr,
Σ̂11
Dᵀ(PZ−PZE )D
(ti)
Again we use binary search to find the values βU and βL such that pivot(βU ) = α/2 and pivot(βL) = 1−α/2
and the confidence interval will be (βL, βU ).
12 Additional Simulation Results
12.1 Empirical CDF of the Conditional P-values
We use the same data generating model as in the main manuscript and plot the empirical CDF of the
conditional p-values under H0 : β
∗ = 1 to compare with the uniform distribution. Figure 5a and 5b show
the result for TSLS estimator with level of endogeneity, Σ∗12 = 0.3, 0.99, or
Σ∗12
Σ∗11Σ
∗
22
= 0.3, 0.99 since we fix
Σ∗11 = Σ
∗
22 = 1.. The magnitude of γ
∗ is varied by the value r where γ∗j = r for every j and r ranges from
0.04 to 2.5.
Figure 6 shows the result for the AR statistic with Σ∗12 = 0.8, and figure 7a and 7b are with Σ
∗
12 = 0.3, 0.99.
12.2 Confidence intervals comparison
We use the same data generating model as before with ρ = 0.8.
For TSLS test statistic we plot the empirical coverage rates and the average lengths of our proposed
conditional interval and the naive confidence interval as a function of r. In Figure 8, we vary γ∗ associated
with valid and invalid IVs differently, with γ∗ = 0.05 for valid IVs and the ratio between γ∗ for invalid over
valid IVs as along the x axis. The next figure 9 are coverage and average lengths for the same setup but
with higher dimensions p = 100, s = 30. We can see the selection effect is larger. The naive coverages are
much worse.
For the AR statistic, in Figure 10a, we fix γ∗ = 0.03 for valid IVs and vary the ratio between γ∗ for
invalid over valid IVs as along the x axis. in Figure 10b, we fix γ∗ = 0.04 for valid IVs and vary the ratio
between γ∗ for invalid over valid IVs as along the x axis. We can see again that the conditional coverage is
about the guaranteed nominal level 0.95 while naive coverage falls far below.
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(a) ρ = 0.3 (b) ρ = 0.99
Figure 5: TSLS: Empirical CDFs of the conditional pvalues with ρ = 0.3, 0.99
39
Figure 6: Comparison between the CDF of the empirical distribution of the conditional p-values using AR
statistic and the uniform distribution. r represents instrument strength as measured by setting γ∗j = r for
all j.
40
(a) ρ = 0.3 (b) ρ = 0.99
Figure 7: AR: Empirical CDFs of the conditional pvalues with ρ = 0.3, 0.99
41
Figure 8: TSLS: Naive and conditional CI comparison. (n, p, s) = (1000, 10, 3).β∗ = 1., α∗E = 7., ρ = .8.γ
∗ =
0.05 for valid IVs and vary the ratio between γ∗ for invalid over valid IVs.
Figure 9: TSLS: Naive and conditional CI comparison. (n, p, s) = (1000, 100, 30).β∗ = 1., α∗E = 7., ρ =
.8.γ∗ = 0.05 for valid IVs and vary the ratio between γ∗ for invalid over valid IVs.
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(a) γ∗ = 0.03 for valid IVs. (b) γ∗ = 0.04 for valid IVs.
Figure 10: AR: Naive and conditional CI coverage comparison. (n, p, s) = (1000, 10, 3).β∗ = 1., α∗E = 7., ρ =
.8. Vary the ratio between γ∗ for invalid over valid IVs.
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13 Inference with Summary Statistics
Lemma 7. Suppose we have the summary statistics β̂j,Y , se
2(β̂j,Y ), β̂j,D, se
2(β̂j,D) and the data Y,D,Z
follows the defined model. If
(i) ZᵀZ is a diagonal, but not necessarily identity, matrix and
(ii) Y,D,Z are centered to mean zero,
the quantities ZᵀY, ZᵀD,ZᵀZ can be written as
Zᵀ(j)Z(j) =
(n− 1) · se2(β̂1,Y ) + β̂21,Y
(n− 1) · se2(β̂i,Y ) + β̂2i,Y
· c
Zᵀ(j)Y = β̂i,Y ·
(n− 1) · se2(β̂1,Y ) + β̂21,Y
(n− 1) · se2(β̂i,Y ) + β̂2i,Y
· c
Zᵀ(j)D = β̂i,D ·
(n− 1) · se2(β̂1,Y ) + β̂21,Y
(n− 1) · se2(β̂i,Y ) + β̂2i,Y
· c
where c is an unknown constant factor, i.e. they are known up to an unknown factor c.
Theorem 5 (Inference with summarized data). Under the assumptions in Lemma 7, the selective inference
density in (22) is identical, regardless of the value of c.
Proof of Lemma 7. First consider the summary statistics between Y and Z(j). The formula for the OLS
coefficient and standard error are
βˆi,Y =
Zᵀ(i)Y
Zᵀ(i)Z(i)
se(βˆi,Y ) =
√
s2 · (Zᵀ(i)Z(i))−1 =
√
1
n− 1
Y ᵀ(I −HZ(i))Y
Zᵀ(i)Z(i)
=
√√√√ 1
n− 1
[
Y ᵀY
Zᵀ(i)Z(i)
− (
Zᵀ(i)Y
Zᵀ(i)Z(i)
)2
]
=
√
1
n− 1(
Y ᵀY
Zᵀ(i)Z(i)
− βˆ2i,Y )
where HZ(i) =
Z(i)Z
ᵀ
(i)
Zᵀ
(i)
Z(i)
. Combine the two to get Z(i)Y and Y
ᵀY in terms of Zᵀ(i)Z(i) with n sample size:
Zᵀ(i)Y = βˆi,Y · (Zᵀ(i)Z(i))
Y ᵀY =
(
(n− 1) · se2(βˆi,Y ) + βˆ2i,Y
)
· (Zᵀ(i)Z(i)) = ki · (Zᵀ(i)Z(i))
Denote c = Zᵀ(1)Z(1), then Y
ᵀY = k1 · c, and that Zᵀ(i)Z(i) = k1ki · c, Z
ᵀ
(i)Y = βˆi
k1
ki
· c.
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Similarly for D and Zi, we have
Zᵀ(i)D = βˆi,D · (Zᵀ(i)Z(i)) = βˆi,D ·
k1
ki
· c
as the formulae given in the lemma.
Proof of Theorem 5. We are going to show the conditional density in Corollary 1 is the same no matter the
value of c. Let us consider the several components in the density.
• Select E from SisVive procedure:
min
αˆ,βˆ
1
2
||PZ(Y − Zα−Dβ)||22 + λ||α||1
=
1
2
(Y − Zα−Dβ)ᵀZ(ZᵀZ)−1Zᵀ(Y − Zα−Dβ) + λ||α||1
=
1
2
(ZᵀY − (ZᵀZ)α− ZᵀDβ)ᵀ(ZᵀZ)−1(ZᵀY − (ZᵀZ)α− ZᵀDβ) + λ||α||1
λ ∼ c based on the way it was chosen (Negahban et al., 2012), and the `2 term also has the factor c,
hence the entire optimization problem is the same up to c, and the selection result would be the same,
i.e. E will be the same.
Also the selection event B will also be the same based on the same E.
Specifically, the optimization problem can be solved as a Lasso with response (ZᵀZ)−
1
2ZᵀY , the design(
(ZᵀZ)
1
2 (ZᵀZ)−
1
2ZᵀD
)
and coefficients
α
β
.
• Estimate β̂TSLS
β̂TSLS =
Dᵀ(PZ − PZE )Y
Dᵀ(PZ − PZE )D
=
(ZᵀD)ᵀ(ZᵀZ)−1(ZᵀY )− (ZᵀED)ᵀ(ZᵀEZE)−1(ZᵀEY )
(ZᵀD)ᵀ(ZᵀZ)−1(ZᵀD)− (ZᵀED)ᵀ(ZᵀEZE)−1(ZᵀED)
=
∑
i
Zᵀi D·Zᵀi Y
Zᵀi Zi
−∑i∈E Zᵀi D·Zᵀi YZᵀi Zi∑
i
(Zᵀi D)2
Zᵀi Zi
−∑i∈E (Zᵀi D)2Zᵀi Zi
where ZᵀZ is diagonal and plugging in formulae in lemma 7 we can see that β̂TSLS is unchanged with
c.
• Estimate of covariance term Σˆ11
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Consider the reduced-form model
Y = ZE(β
∗γ∗E + α
∗
E) + Z−E(γ
∗
−Eβ
∗) + ξ1
D = Zγ∗ + ξ2
where (ξi1, ξi2) ∼ N(0,Ω∗). As common in MR, we also assume that Ω∗12 = 0, and the reduced form
model is no different than a pair of OLS regression models in terms of estimating the covariance Ω∗:
Ωˆ =
s2Y Z 0
0 s2DZ

where
s2Y Z =
1
n− p+ 1
∑
i
(Yi − βˆi,Y Zi)2 = 1
n− p+ 1[Y
ᵀY −
∑
i
(Zᵀi Y )
2
Zᵀi Zi
]
s2DZ =
1
n− p+ 1
∑
i
(Di − βˆi,DZi)2 = 1
n− p+ 1[D
ᵀD −
∑
i
(Zᵀi D)
2
Zᵀi Zi
]
where from standard OLS regression formulae we know that with orthogonal design matrix Z the
individual coefficients of the marginal OLSs are the same as the coefficients in the multivariate OLS
with all the Zi’s together.
From the one-to-one mapping and plug in a consistent estimator of β∗ such as β̂TSLS , we can obtain
a consistent estimate of Σ∗
Σ̂ =
1 −β̂TSLS
0 1
 Ω̂
 1 0
−β̂TSLS 1

Σ̂ has the factor c.
• Covariance terms:
The covariance of the asymptotic distribution of TSLS estimator
Cov(β̂TSLS) =
Σ̂11
Dᵀ(PZ − PZE )D
=
Σ̂11
DᵀZ(ZᵀZ)−1ZᵀD −DᵀZE(ZᵀEZE)−1ZᵀED
the factor c cancels with the numerator and denominator and hence Cov(β̂TSLS) does not change with
c.
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ΣS,T =
Σ̂11
Dᵀ(PZ − PZE )D
Zᵀ(PZ − PZE )D
Dᵀ(PZ − PZE )D

= Cov(β̂TSLS) ·
 ZᵀD − ZᵀZE(ZᵀEZE)−1ZᵀED
DᵀZ(ZᵀZ)−1ZᵀD −DᵀZE(ZᵀEZE)−1ZᵀED

ΣS,T has the factor c.
• Selective density
`β0(βTSLS , α, β, u−E) ≈ φβ0, Σ̂11Dᵀ(PZ−PZE )D
(βTSLS) · I(B)
· g
−ΣobsS,T · βTSLS +
 ZᵀZ ZᵀD
(ZᵀD)ᵀ DᵀPZD
+ I
obsα
β
+ λ
u
0
−
 ZᵀY
DᵀPZY
− ΣS,T · βTSLS
obs

The way we set the randomization g scales with c, as well as λ, and the terms inside g also has the
factor c, hence overall g(·) and also φ(·) both have the same value as c changes.
14 Application: a Developmental Economics Dataset
It is of interest to study the relationship between income and expenditures on goods and services in develop-
mental economics, and specifically the efficient wage hypothesis, which suggests that the increased income
would lead to workers being better fed, and eventually result in better worker productivity, especially in
developing economies. We are going to apply our method to a real dataset in development economics, as
a follow-up and comparison to the analysis in Kang et al. (2015), which had been analyzed in Bouis and
Haddad (1990) and Bouis (1992).
The dataset has n = 405 observations of Philippine farm households, and the outcome Yi is household
food expenditures, the treatment Di is household’s log income. We are interested in analyzing the effect
of income Di on demand for food Yi. There are L = 4 instrument candidates, namely cultivated area per
capita Zi1, worth of assets Zi2, binary indicator of household electricity Zi3, and the house flooring quality
Zi4. There are also covariates Xj ’s, namely mother’s education, father’s education, mother’s age, father’s
age, mother’s nutritional knowledge, price of corn, price of rice, population density of the municipality, and
number of household members in adult equivalents (c.f. page 82 of Bouis and Haddad (1990)).
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In terms of the general model, there will be exogenous variable Xj ’s in the structural model
Yi = Z
T
i α
∗ +XTi κ+Diβ
∗ + δi
Di = Z
T
i γ
∗ +XTi pi + ξi2
we can replace the variables Yi, Di, Zi with the residuals after regressing them on X, i.e. replace Y,D,Z by
Y˜ = (I −PX)Y, D˜ = (I −PX)D, Z˜ = (I −PX)Z (Wang and Zivot 1998), hence to get rid of the dependence
on nuisance parameters (κ, pi) and the resulting sufficient statistic does not involve X for β∗. The rest of the
analysis proceeds exactly the same with Y˜ , D˜, Z˜.
In the original setup of Kang et al. (2015), there is a parameter U as the sensitivity parameter and
be provided by the researcher as an upper bound on the number of invalid instruments in the model, i.e.
U > s, with smaller U representing a larger confidence that most instruments are valid and vice versa. In
our analysis, we will also report confidence intervals for different given values of U , to better compare with
the other analysis.
In below table 1, U = 1 means it is believed to be no invalid IVs and the confidence interval is the same
as the classical one; for U = 2 our procedures always picks Z2 as invalid and the resulting intervals with
TSLS or AR statistic are shown; for U = 3 our procedures always picks Z2, and the first lines are intervals
when picking Z1 additionally, and the second lines are intervals otherwise. In table 2, the intervals from
Kang et al. (2015) are shown with corresponding U values. On the high level, their intervals is constructed
to be the union of all the intervals given possible enumerations of the invalid IVs with s < U .
Generally speaking, when U > 1 meaning there is possibly invalid instruments in the model, the selective
confidence intervals tend to be longer than those merely based on TSLS statistics, and the difference tends
to be larger when U increases, i.e. when there might be many invalid instruments. Because our approach
conditions on the actual selection result, there will be more than one possible confidence interval based on
the observed selection result. This could be expected because of the randomized nature of our method, just
like the results are also based on the random model chosen by data splitting. Our method is valuable when
the researcher trusts in the data-driven method to detect the invalid IVs, and the model will only be based
on the selection result. It can also be seen that even with the union of our intervals for a given U , our interval
is slightly shorter than theirs, possible because of the power increase from our randomized procedure.
Table 1: Selective confidence intervals
Test U = 1 (Naive) U = 2 U = 3
TSLS (0.043, 0.053) (0.034, 0.058) (−0.007, 0.012)
(0.037, 0.064)
AR (0.044, 0.054) (0.042, 0.051) (−0.015, 0.031)
(0.038, 0.063)
Remark 14.1. If we directly fit an OLS of D on Z, the t-values are 8.163, 8.232, 1.080, 2.774 and we can see
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Table 2: Kang et al. (2015) confidence intervals
Test U = 1 (Naive) U = 2 U = 3
TSLS (0.043, 0.053) (0.031, 0.059) (−0.017, 0.064)
AR (0.044, 0.054) (0.037, 0.058) (−0.027, 0.068)
that the most significant one is the 2nd IV which is always picked up first. When it then picks up the 1st
IV, the remaining IVs are relatively weakly correlated with D, and the resulting confidence intervals contain
0. When it then picks up either the 3rd or the 4th IV, the remaining IVs (including the 1st IV) are more
correlated with D, and the resulting confidence intervals do not contain 0 and much resemble those for U = 2
case. But of course these uncertainly come from the data itself, any conditional inference has to deal with
this ambiguity of the validity of instruments. Selective inference is trying to eliminate the selection bias on
top of this.
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